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This review covers the literature published in 2013 for marine natural products (MNPs), with 982
citations (644 for the period January to December 2013) referring to compounds isolated from
marine microorganisms and phytoplankton, green, brown and red algae, sponges, cnidarians,
bryozoans, molluscs, tunicates, echinoderms, mangroves and other intertidal plants and
microorganisms. The emphasis is on new compounds (1163 for 2013), together with the relevant
biological activities, source organisms and country of origin. Reviews, biosynthetic studies, ﬁrst
syntheses, and syntheses that lead to the revision of structures or stereochemistries, have been
included.1 Introduction
2 Reviews
3 Marine microorganisms and phytoplankton
3.1 Marine-sourced bacteria (excluding from mangroves)
3.2 Bacteria from mangroves
3.3 Marine-sourced fungi (excluding from mangroves)
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17 References1 Introduction
This review is of the literature for 2013 and describes 1163
new compounds from 379 articles, a 6% decrease in the
number of compounds reported in 2012.1 As in previous
reviews, the structures are shown only for new compounds, or
for previously reported compounds where there has been a
structural revision or a newly established stereochemistry.
Previously reported compounds for which rst syntheses or
new bioactivities are described are referenced, but separate
structures are generally not shown. Where the absolute
conguration has been determined for all stereocentres in a
compound, the identifying diagram number is distinguished
by addition of the † symbol.2 Reviews
A selection of the many reviews on various aspects of MNP
studies is listed here. A comprehensive review of MNPs reported
in 2011 has appeared,2 as well as the highlights of compounds
reported in 2012.3 Marine pharmacology papers for 2009–2011
have been collated,4 two reviews summarise natural products
(NPs), including from marine sources, as drug leads,5,6 while
another paper describes recent advances in marine drug
research.7 A synopsis of the project BAMMBO for the sustain-
able production of biologically active molecules of marine
based origin has appeared.8 General classes of compounds have





















































































View Article Onlineagents,9 alkaloids from corals,10 meroterpenes from marine
invertebrates,11 ‘head-to-sidechain’ cyclodepsipeptides,12
marine alkaloids containing an 1-(indol-3-yl)ethane-1,2-
diamine fragment,13 tetrahydrofuran-containing macrolides,14John Blunt obtained his BSc
(Hons) and PhD degrees from the
University of Canterbury, fol-
lowed by postdoctoral appoint-
ments in Biochemistry at the
University of Wisconsin–Madi-
son, and with Sir Ewart Jones at
Oxford University. He took up a
lectureship at the University of
Canterbury in 1970, from where
he retired as an Emeritus
Professor in 2008. His research
interests are with natural prod-
ucts, the application of NMR techniques to structural problems, and
the construction of databases to facilitate natural product investi-
gations.
Brent Copp received his BSc
(Hons) and PhD degrees from the
University of Canterbury, where
he studied the isolation, structure
elucidation and structure–
activity relationships of biologi-
cally active marine natural
products under the guidance of
Professors Blunt and Munro. He
undertook postdoctoral research
with Jon Clardy at Cornell and
Chris Ireland at the University of
Utah. 1992–93 was spent
working in industry as an isolation chemist with Xenova Plc, before
returning to New Zealand to take a lectureship at the University of
Auckland, where he is currently an Associate Professor.
Rob Keyzers carried out his
BSc(Hons) and PhD studies at
Victoria University of Wellington.
His thesis research, carried out
under the guidance of Assoc. Prof.
Peter Northcote, a former
contributor to this review,
focused on spectroscopy-guided
isolation of sponge metabolites.
He then carried out post-doctoral
research with Mike Davies-Cole-
man (Rhodes University, South
Africa) and Raymond Andersen
(University of British Columbia, Canada) before a short role as a
avour and aroma chemist at CSIRO in Adelaide, Australia. He was
appointed to the faculty at his alma mater in 2009 where he is
currently a Senior Lecturer.
This journal is © The Royal Society of Chemistry 2015terpenes from Sarcophyton sp.,15,16 antimicrobial peptides from
proteobacteria,17 diarrhetic shellsh toxins in Washington
State.,18 di- and sesquiterpenes from Cystosiera sp.,19 and halo-
genated compounds from Rhodomelaceae.20 Some general
reviews on various classes of compounds include data on
marine compounds – anticancer steroids,21 sesterterpenoids,22
NPs containing a nitrogen–nitrogen bond,23 and muscarine,
imidazole, oxazole and thiazole alkaloids.24 Reviews on various
aspects of specic compounds include lamellarins N and L,25
STX,26 lyngbouilloside and related macrolides,27 thiomarinol
and related dithiolopyrrolone compounds,28 okadaic acid,29 and
the marinopyrroles.30 There have been many reviews covering a
variety of groups of marine organisms, including bioprospect-
ing of plankton,31 actinomycetes,32,33 S. China Sea opistho-
branch molluscs,34 actinobacteria,35,36 lamentous marine
cyanobacteria,37 and microbes in general.38–40 Reviews on
specic organisms include Australian Dicathais orbita,41
metabolites from Osmundaria spp.,42 Aspergillus spp.,43 and
Bacillus spp.44 A focus on bioactivities is made in reviews on
anti-inammatory compounds,45,46 trypanocidal products,47
neuroprotective compounds,48 antitumour/anticancerMurray Munro, Emeritus
Professor in Chemistry at the
University of Canterbury, has
worked on natural products right
through his career. This started
with diterpenoids (PhD; Peter
Grant, University of Otago), fol-
lowed by alkaloids during a
postdoctoral spell with Alan Bat-
tersby at Liverpool. A sabbatical
with Ken Rinehart at the Univer-
sity of Illinois in 1973 led to an
interest in marine natural prod-
ucts with a particular focus on bioactive compounds which has
continued to this day. In recent years his research interests have
widened to include terrestrial/marine fungi and actinomycetes.
Miche`le Prinsep received her BSc
(Hons) and PhD degrees from the
University of Canterbury, where
she studied the isolation and
structural elucidation of biologi-
cally active secondary metabo-
lites from sponges and bryozoans
under the supervision of Profes-
sors Blunt and Munro. She
undertook postdoctoral research
on cyanobacteria with Richard
Moore at the University of
Hawaii before returning to New
Zealand to take up a lectureship at the University of Waikato, where
she is currently a Senior Lecturer.





















































































View Article Onlineagents,49–52 kinase inhibitors,53 anti-Herpes simplex agents,54
anti-HIV actives,55 angiogenesis inhibitors,56 cardioprotective
peptides,57 antithrombotic peptides,58 antimicrobial peptides,59
therapeutics for Gram-negative sepsis,60 and bioactives from
Antarctic and Arctic organisms.61 The chemical ecology of
plankton62 and the possible ecological roles of cyanotoxins63
have been reviewed. The eighth in a companion series providing
an overview of synthetic aspects of MNPs has appeared with
coverage of publications from 2010.64 Further reviews of
syntheses of specic compounds include marine alkyl
purines,65 tetrodotoxin,66 (+)-spirastrellolide A methyl ester,67
and 'upenamide, the structure of which still remains elusive.68 A
number of papers which, while not necessarily being reviews,
are useful to reference here as they describe advances in tech-
niques or approaches to discovery that are relevant to MNP
studies. These include papers on novel extraction technologies
for bioactives from marine algae,69 dereplication of marine
actinomycetes by LCHRMS proling,70 X-ray analysis on the
nanogram to microgram scale using porous complexes,71,72
rapid screening of bioactive compounds by integrating 5-
channel parallel chromatography coupled with on-line mass
spectrometry and microplate based assays,73 molecular
networking as a dereplication strategy,74 NMR-based metab-
olomic analysis of macroalgae,75 biogeography and biodiscovery
hotspots of macroalgal compounds,76 and coral aquaculture to
support drug discovery.77 The MarinLit database has been
updated and was used as the literature source for the prepara-
tion of this present review. This database has now been trans-
ferred to the Royal Society of Chemistry from where it is
available as a web-accessible version.783 Marine microorganisms and
phytoplankton
MNP research eﬀort is being increasingly directed towards
marine microorganisms with 491 new compounds reported in
2013, an increase of 14% from 2012 (see 15 Conclusion). Unless
otherwise stated, compounds described in this section were
obtained from cultures of the named microorganisms.3.1 Marine-sourced bacteria (excluding from mangroves)
The chlorinated pyrones halomadurone A 1 and B 2 were iso-
lated from Actinomadura sp. (ascidian Ecteinascidia turbinata,
Florida Keys, U.S.A.) and with increased concentration of
potassium bromide in the growth media produced the bromi-
nated analogues halomadurone C 3 and D 4. The halomadur-
ones A–D activated the nuclear factor E2-related antioxidant
response element, an indication of potential for treatment of
neurodegenerative diseases.79 Discoipyrroles A–D 5–8 are alka-
loids isolated from Bacillus hunanensis (sediment, Galveston
Bay, Texas, U.S.A.) that inhibit the signaling pathway of the
tyrosine kinase, discoidin domain receptor 2. They were each
obtained as racemates and feeding experiments with several
substituted benzaldehyde precursors indicated formation
through a nonenzymic process, which led to a one-pot total
synthesis of discoipyrrole A 5.80118 | Nat. Prod. Rep., 2015, 32, 116–211Three glycosylated methoxy-macrolactins 9–11 were isolated
from Bacillus subtilis (B. subtilis) (sediment, Gageocho, S. Korea)
and all displayed inhibition of Gram-positive and Gram-nega-
tive bacterial strains, in addition to modest antifungal activity.81
A strain of B. subtilis (spongeHaliclona simulans, Gurraig Sound,
Galway, Ireland) yielded subtilomycin, a partially characterised
32-amino acid compound that was partly responsible for the
observed broad spectrum antimicrobial activity of the
bacterium.82
Bacillus sp. (sediment, Ieodo Reef, S. Korea)83 produced the
24-membered macrolactones macrolactin X–Z 12–14 and the
unsaturated fatty acids linieodolide A 15 and B 16, all with
modest antibacterial and antifungal activity.84
Two separate isolates of the myxobacterium Enhygromyxa
salina yielded antibiotics. Salimyxins A 17 and B 18 were
obtained from one strain (sediment, Santa Barbara, Cal-
ifornia, U.S.A.) whilst the geometric isomers enhygrolide A 19
and B 20 were isolated from another strain (sediment, Prerow,
Germany). Salimyxins A 17 and B 18 are structurally very
similar to demethylincisterol obtained from the sponge
Homaxinella sp.,85 whilst enhygrolides A 19 and B 20 are
structurally related to the nostoclides, rst obtained from a
Nostoc species of cyanobacterium.86 Salimyxin B 18 and
enhygrolide A 19 were moderate growth inhibitors of the
Gram-positive bacterium Arthrobacter cristallopoietes.87 The
obligatory marine myxobacterium Enhygromxya salina (sedi-
ment, Prerow Is., Germany) was the source of the tetracyclic
salimabromide 21 which was a moderate inhibitor of Arthro-
bacter cristallopoietes.88
Kocuria palustris (sponge Xestospongia muta, Key Largo,
Florida)89 produced a thiazolyl peptide kocurin 22 with anti-
bacterial activity including strong inhibition of methicillin-
resistant Staphylococcus aureus (MRSA).90 A molecule with the
same planar structure as 22 was previously isolated from





















































































View Article Onlinebelieved to be a correction of the structure previously
assigned to PM181104,92 (also obtained from a Kocuria sp.)
mentioned in a patent.90 Kocurin, also produced by Kocuria
marina and a Micrococcus sp. (Florida Keys),93 has been syn-
thesised by a convergent strategy in good overall yield.94 The
macrolide juvenimicin C 23 was obtained from Micro-
monospora sp. (sediment, Palau) and enhanced the activity of
the enzymes quinone reductase I, glutathione reductase and
glutathione peroxidase, suggesting potential as a cancer
chemopreventive agent.95 Levantilide C 24 is a 20-membered
macrolide isolated from a Micromonospora strain (Golfo Cor-
covaclo, Chiloe Is., Chile) with moderate antiproliferative
activity against human tumour cancer cell lines (HTCLs).96
Two strains of Micromonospora (sediment, North Carolina
coast, U.S.A.) yielded the polyene macrolactam micro-
monolactam 25, a constitutional isomer of salinilactam A97
but with a diﬀerent polyene pattern and a (Z)-double bond,This journal is © The Royal Society of Chemistry 2015in contrast to the all (E)-structure of salinilactam A. Genome
sequencing of one of the strains determined that 25 was
derived from eleven polyketide units and a modied
glutamate starter unit.98 Nocardiopsis alba (deep-sea sedi-
ment, Indian Ocean) produced several diketopiperazines,
including the new C-6 epimers nocazine D 26 and E 27
and the known synthetic compounds (S,Z)-3-benzylidene-6-
methylpiperazine-2,5-dione and (S,Z)-3-benzylidene-6-iso-





















































































View Article Onlineas NPs. Methoxyneihumicin was also isolated. This is a
structure that had been previously reported in a conference
poster100 but not in the chemical literature. Both methox-
yneihumicin and the known bacterial metabolite XR334
(ref. 101) (rst time marine isolate) were modestly active
against HTCLs.102
Three diﬀerent groups of researchers have isolated
metabolites from Nocardiopsis species and all have named
them nocapyrones. To avoid confusion they are presented
here in order of publication. Firstly, symbiotic Nocardiopsis
alba (cone snail Conus rolani, Mactan Is., Philippines)
produced the g-pyrones nocapyrone H–Q 28–39. Of these,
nocapyrone N 35/36 was isolated as a mixture of enantiomers
in a 10 : 1 ratio and nocapyrone M 33/34 occurred as an
inseparable mixture of diastereoisomers. Both nocapyrone H
28 and the co-isolated nocapyrone B, previously obtained
from a sponge-associated Nocardiopsis strain,103 modulated120 | Nat. Prod. Rep., 2015, 32, 116–211nerve cell depolarisation and were active against a wide range
of dorsal root ganglion neuronal cell types. Nocapyrones B
and H were moderately cytotoxic to cancer cell lines.104
Secondly, three 3,6-disubstituted a-pyrones 40–42 were iso-
lated from Nocardiopsis sp. (sediment, Ulleung Basin, Eastern
sea, Korea) and named nocapyrones H–J. “Nocapyrone H” 40
inhibited pro-inammatory factors such as nitric oxide (NO),
prostaglandin E2 (PGE2) and interleukin-1b (IL-1b) (potential
neuroprotective eﬀects).105 Lastly, Nocardiopsis dassonvillei
subsp. dassonvillei (sediment, Lianyungang, China) also
produced a-pyrones named “nocapyrones H–N”. Of these
“nocapyrone H” had the same structure as 40, “nocapyrone K”
was identical to 41, while the balance, 43–47, were unique.
“Nocapyrone I” 43 and “M” 46 displayed inhibition of quorum
sensing (QS) controlled gene expression in Chromobacterium
violaceum CV026 and Pseudomonas aeruginosa QSIS-lasI





















































































View Article OnlineVery clearly the naming of these metabolites needs revision.
Saline culture of Nocardiopsis sp. (sediment, S. Molle Is.,
Queensland, Australia) previously yielded norcardioazines A
and B107 whilst non-saline culture of the same strain yielded
nocardiopsins A and B.108 Further investigation of the strain
cultivated under non-saline conditions has resulted in the
isolation of the prolinyl-macrolactam polyketides nocardiopsin
C 48 and D 49 and the highly substituted a-pyrone polyketide,
nocardiopyrone A 50.109 It should be noted that the name
nocardiopyrone A has coincidentally been given to a metabolite
isolated from a terrestrial species, Nocardiopsis alkaliphila,110
and that the same CAS number appears to have been given to
both compounds in error on the Scinder database, with the
terrestrial compound structure showing as corresponding to
that CAS number.This journal is © The Royal Society of Chemistry 2015The cyclic hexapeptides nocardiamide A 51 and B 52 were
isolated from Nocardiopsis sp. (La Jolla Canyon, San Diego,
California, U.S.A.) and then synthesised via solid-phase peptide
synthetic methods.111 Amicroorganism, nominally Paenibacillus
profundus sp. nov., (sediment, Sea of Japan) yielded a linear
glyceryl acid derived heptapeptide 53 with strong antibacterial
inhibition and moderate inhibition of SK-MEL-28 cells,112 while
a species of Photobacterium, closely related to P. halotolerans
(mussel, Solomon Is., Pacic Ocean), was the source of the
cyclodepsipeptides ngercheumicin F–I 54–57 that inhibited
quorum sensing in Staphylococcus aureus.113
A Pseudoalteromonas sp. (oil-contaminated surface water,
Gulf of Mexico aer the Deepwater Horizon oil spill) yielded
the siderophores lystabactin A–C 58–60 which contained
the unusual nonproteinogenic amino acid 4,8-diamino-3-
hydroxyoctanoic acid (LySta). Since lystabactin C is 29-methoxy
lystabactin A, it may have been an artefact of isolation.114
Cyanosporasides A and B are chloro- and cyano-cyclopenta[a]
indene glycosides originally isolated from a Palauan Salinispora
pacica strain,115 while cyanosporasides C–E 61–63 came from
investigation of another S. pacica strain (sediment, Palau) and
cyanosporasides D–F 62–64 from a Streptomyces sp. (sediment,
Bahamas). Cloning, sequencing, and mutagenesis of cyano-
sporaside biosynthetic gene clusters from both bacteria
demonstrated that the cyanosporasides are enediyne poly-
ketides and a two-gene operon was identied which was
implicated in the nitrile functionalisation of these metabo-
lites.116 Further investigation of the strain of S. pacica (USDA
Agricultural Research Service) that produced lomaiviticins C–
E117 resulted in the isolation of ()-homoseongomycin 65.
Synthesis of an isotopically-labelled derivative, homo-
seongomycin-d5, claried aspects of the biosynthetic
pathway.118
The alkaloid 66 was obtained from Serinicoccus profundi sp.
nov. (deep-sea sediment, Indian Ocean) (weak activity against
Staphylococcus aureus (S. aureus))119 and Staphylococcus sp. (red
alga, Corallina oﬃcinalis, Nagasaki Shitsu Coast, Japan)
provided the diketopiperazine derivatives staphyloamide A 67
and B 68.120 Streptomyces antibioticus (sediment, source not
given) yielded the indanomycin-related antibiotics 69–71 as
moderate growth inhibitors of S. aureus.121
The alkaloids nitrosporeusine A 72 and B 73 with an
unprecedented skeleton (benzenecarbothioc cyclopenta[c]
pyrrole-1,3-dione) were isolated from S. nitrosporeus (sediment,
Arctic Chukchi Sea). Both nitrosporeusines inhibited the H1N1





















































































View Article Onlinenaphthoquinones marfuraquinocin A–D 74–77 and the ger-
anylated phenazines phenaziterpene A 78 and B 79 were iso-
lated from S. niveus (sediment, S. China Sea). Marfuraquinocins
A 74 and C 76 were growth inhibitors of NCI–H460 cancer cells
(moderate) whilst marfuraquinocins A, C and D 77 were
moderate growth inhibitors of S. aureus, with marfuraquinocins
C and D also inhibitors of methicillin-resistant Staphylococcus
epidermidis.123
Tetroazolemycins A 80 and B 81 are oxazole/thiazole deriv-
atives obtained from S. olivaceus (deep-sea water, southwest
Indian Ocean), both of which showed binding aﬃnity for the
metal ions Fe3+, Cu2+ and Zn2+.124 S. seoulensis (shrimp gut
Penasus orientalis, Qingdao, China) yielded the neuraminidase
inhibitors streptoseolactone 82, limazepine G 83 and a known
synthetic compound125,126 isolated for the rst time as an NP,
and named limazepine H.127 Endophytic S. sundarbansensis
(brown alga Fucus sp., Bejaia, Algeria) provided the polyketide
chromanone 84 (modest but selective activity against MRSA).128122 | Nat. Prod. Rep., 2015, 32, 116–211S. tateyamensis (sponge Haliclona sp., Tateyama City,
Japan)129 was the source of JBIR-107 85,130 while the phenox-
azine-based alkaloids venezueline A–E 86–90 and the amino-
phenols venezueline F 91 and G 92 were obtained from S.
venezuelae (sediment, Guam) with the known analogues exfo-
liazone,131 chandrananimycin D132 and carboxyexfoliazone,133 all
previously obtained from terrestrial Streptomyces species but
now rst timemarine isolates. Venezueline B 87was moderately
cytotoxic towards a panel of HTCLs.134
Double mutation of a strain of S. xiamenensis (sediment,
Eastern Pacic Ocean) led to production of two benzopyran
derivatives xiamenmycin C 93 and D 94, which both inhibited
proliferation of human lung broblasts (WI26),135 and Strepto-
myces sp. (unidentied so coral, Weizhou Is., Guangki Prov-
ince, China) was the source of the chlorinated polyketides
strepchloritide A 95 and B 96 cytotoxic against MCF-7 cells
(modest).136 Chlorizidine A 97, comprised of a chlorinated 2,3-
dihydropyrrolizine ring attached to an unprecedented chlori-





















































































View Article OnlineStreptomyces strain (sediment, San Clemente, California, U.S.A.)
and was moderately cytotoxic to a panel of HTCLs.137 The
biosynthetic gene cluster of chlorizidine A 97 was identied and
whole pathway heterologous expression and genetic manipu-
lations were utilised to show that it is assembled by a polyketide
synthase (PKS) that uniquely incorporates a fatty acid synthase-
derived dichloropyrrolyl extender unit into the pyrroloisoindo-
lone enzymic product.138
The diketopiperazine derivatives 98–102 were obtained from
Streptomyces sp. (sediment, Huanghai Beach, Dalian, China)This journal is © The Royal Society of Chemistry 2015and 100 displayed modest activity against the inuenza A
(H1N1) virus, whilst the co-isolated fungal metabolites (3Z,6S)-
3-benzylidene-6-isobutylpiperazine-2,5-dione139 and albo-
moursin140 displayed potent inhibition of the virus and were
rst time marine isolates.141
Streptomyces sp. (sediment, S. China Sea) yielded the spi-
rotetronate lobophorin G 103, a potent inhibitor of both Myco-
bacterium bovis Bacillus Calmette-Guerin (BCG) and B. subtilis
and a moderate inhibitor of Mycobacterium tuberculosis (M.
tuberculosis).142 Sungsanpin 104 isolated from a Streptomyces sp.
(deep-sea sediment, Jeju Is., S. Korea) is an example of a so-
called lasso peptide, a ribosomally synthesised peptide of
between 16 and 23 amino acids with an N-terminal eight- or
nine-residue ring with a linear C-terminus threaded through the
ring.143 Sungsanpin inhibited A549 cells in a cell invasion





















































































View Article OnlineInvestigation of two diﬀerent Streptomyces strains identied
six new napyradiomycin analogues. The Streptomyces strain
CNQ-329 (sediment, San Diego, California, U.S.A.) produced
napyradiomycins A–E 105–109, while strain CNH-070 (sedi-
ment, San Elijo Lagoon, Encinitas, California, U.S.A.) produced
napyradiomycin F 110.
Four of the napyradiomycins A, D–F were cytotoxic
(moderate) to HCT-116 cells whilst napyradiomycins A and B
inhibited MRSA (moderate).
Also isolated were napyradiomycins B2–B4; B3 (ref. 145) and
B4 (ref. 146) as rst time marine isolates.147 Three napyr-
adiomycins, 4-dehydro-4a-dechloronapyradiomycin A1 111, 3-





















































































View Article Onlinedihydroxy-8-a-lapachone 113 isolated from a Streptomyces
species (sediment, Xieyang Is., Beihai, Guangxi Province, China)
displayed moderate inhibition of several Gram-positive bacteria
while 3-dechloro-3-bromonapyradiomycin A1 112 was moder-
ately active against several HTCLs.148 A Streptomyces sp. (sedi-
ment, Santa Barbara, California, U.S.A.) yielded the antibiotic
anthracimycin 114, signicantly active against Bacillus anthra-
cis. Early in vivo results indicated that 114 also provided
signicant protection against MRSA cell lines. The planar
structure of anthracimycin 114 may have been published in aThis journal is © The Royal Society of Chemistry 20152011 patent149 but insuﬃcient detail was given to permit a full
comparison.150
Surugamides A–E 115–119, cyclic octapeptides with four D-
amino acid residues, were obtained from Streptomyces sp.
(deep-sea sediment, Kinko Bay, Japan) and were modest
inhibitors of the protease enzyme bovine cathepsin B.151 Three
strains of S. champavatii (sediment, Gotland Deep and Kiel
Bight, Baltic Sea and Urania Basin, Eastern Mediterranean)
produced the octapeptide champacyclin 120, an inhibitor of the
bacterium Erwinia amylovora, the causative agent of re blight





















































































View Article Onlineplanar structure as surugamide A 115 but diﬀerent congura-
tions at two amino acid residues. Champacyclin was also
prepared by solid-phase peptide synthesis.152
Streptomyces sp. (sediment, S. China Sea) yielded the pre-
gnene steroid 3219A 121 with a rare D8,9-double bond in the
skeleton,153 and the polyketide nahuoic acid A 122 was
obtained from a Streptomyces sp. (sediment, Padana Nahua,
Papua New Guinea) as a selective SAM-competitive inhibitor126 | Nat. Prod. Rep., 2015, 32, 116–211of the histone methyltransferase enzyme SETD8.154 A mer-
oterpenoid actinoranone 123 was isolated from a bacterium,
likely a Streptomyces species (sediment, San Diego, California,
U.S.A.)155 as a moderate cytotoxin of HCT-116156 and Strepto-
myces sp. (sediment, Marsa Matruh city, Egypt) was the source
of maroxazinone 124, moderately cytotoxic to several
HTCLs.157
Farnesides A 125 and B 126, linear sesquiterpenoids con-
nected by ether linkages to a ribose dihydrouracil nucleoside,
came from Streptomyces sp. (sediment, Nacula Is., Yasawa Is.,
Fiji) with farneside A modestly active against Plasmodium falci-
parum (P. falciparum).158
A PCR-based genetic screening experiment targeting the





















































































View Article Onlinea Streptomyces sp. (sediment, Heishijiao Bay, Dalian, China)
could potentially produce glycosidic antibiotics. Further
investigation of this strain yielded the 6-deoxyhexose-con-
taining antibiotics, 110,120-dehydroelaiophylin 127 and 11,110-
O-dimethyl-140-deethyl-140-methylelaiophylin 128, of which
127 was an inhibitor of MRSA and vancomycin-resistant
Enterococci pathogens. The elaiophylin derivative 128 might
be an artefact resulting from methanolysis during the isola-
tion procedure.159
The cyclic peptides ohmyungsamycin A 129 and B 130 were
isolated from a Streptomyces sp. (sand, Shinyang Beach, Jeju Is.,
S. Korea). During determination of congurations a new
method to determine the absolute conguration of N,N-dime-
thylvaline was developed which utilises phenylglycine methyl
ester derivatisation coupled with chromatographic analysis and
provides a general and convenient method for determination of
the congurations of amino acids with fully substituted amine
groups. Ohmyungsamycins A 129 and B 130 inhibited growth of
several HTCLs and of Gram-positive and Gram-negative
bacteria with ohmyungsamycin A 129 being much more potent
than B 130.160
Separacenes A–D 131–134 are polyene polyols obtained
from Streptomyces sp. (sediment, Jeju Is., S. Korea).This journal is © The Royal Society of Chemistry 2015Separacenes A 131 and B 132 are C-3 epimers whilst separa-
cenes C 133 and D 134 are C-12 epimers. Separacene A 131 was
a modest inhibitor of Candida albicans (C. albicans) isocitrate
lyase and two HTCLs.161
Streptomyces sp. (deep-sea sediment, S. China Sea) was the
source of lobophorins H 135 and I 136 of which lobophorin H
135 exhibited signicant inhibition of B. subtilis and moderate
inhibition of S. aureus while lobophorin I 136 was much less
active.162
The polycyclic polyketide akaeolide 137 was isolated
from a Streptomyces sp. (sediment, Miyazaki Harbour,
Japan) as a modest cytotoxin to 3Y1 rat broblasts.163 Strep-
sesquitriol 138, a caged sesquiterpene isolated from Strep-
tomyces sp. (sediment, Bay of Bengal, Indian Ocean), was a
moderate inhibitor of lipopolysaccharide-induced TNFa
production in RAW264.7 macrophages,164 while cyclohexi-
mide acid A 139 was obtained from Streptomyces sp.
(seawater, E. China Sea, Wenzhou, Zhejiang Province,
China).165
The immunosuppressant cyclic lipopeptides thalasso-
spiramides A and B were originally obtained from the a-
proteobacterium Thalassospira sp.166 Reinvestigation of the
original producer, a second strain of Thalassospira (source
not given), Tistrella mobilis (Red Sea167) and Tistrella bauza-
nensis (Pacic Ocean167) led to the isolation of fourteen
analogues thalassospiramides A1–A5 140–144, C 145 and C1
146, E 147 and E1 148, B1 149 and B2 150, D 151 and D1 152
and thalassospiramide F 153 that have been subdivided into
six structural classes with variations in the length and





















































































View Article Onlinestructures of 149 and 152 were described in a patent as
metabolites of another a-proteobacterium, Oceanospirillum
sp.168 and potent inhibitors of the cysteine protease calpain 1.
In the current study selected thalassospiramides (A, A1, B, C,
D1 and E1) were tested and all displayed potent activity
against calpain 1. Biosynthetic gene clusters for all four
bacterial strains were characterised revealing some atypical
NRPS biochemical features such as intrasynthetase trans A
domain activation, module skipping and multimodule itera-
tion which likely yield the structural diversity.169 Thalasso-
spira sp. (brown alga Rosenvingea sp., Bahamas) yielded a
further member of the thalassospiramide family of peptides,
thalassospiramide G 154. The co-isolated thalassospiramides
A166 and D169 were moderate inhibitors of NO production in
lipopolysaccharide (LPS)-stimulated mouse macrophage
RAW 264.7 cells.170
The 18-membered macrolide macplocimine A 155 was
obtained from the lamentous sulfur bacterium Thioploca sp.
(benthic microbial mat, Chile).171 Verrucosispora sp. (deep-sea
sediment, S. China Sea) was the source of three further abys-
somicin polyketides abyssomicin J–L 156–158. Abyssomicin C172
was also isolated and converted to abyssomicin J 156. In vitro
and cell-based analytical studies were then used to show that
abyssomicin J 156 can act as a prodrug which, upon oxidative128 | Nat. Prod. Rep., 2015, 32, 116–211activation, will be selectively transformed to atrop-abyssomicin
C,173 an anti-TB antibiotic.174
Heronamide A, a polyketide macrolactam originally
obtained from an Australian, sediment-derived Streptomyces
sp.,175 was reisolated from a Streptomyces sp. (sediment, Ura-
nouchi Bay, Kochi Prefecture, Japan). Detailed NMR analysis of
heronamide A and derivatives resulted in congurational reas-





















































































View Article Onlinethe congurations of heronamides B175 and C175 should be
reinvestigated.176
The conguration of the a-methylserine residue in the
tetrapeptides JBIR-34 and JBIR-35 and in the trichostatin
analogue JBIR-111, originally obtained from a sponge-derived
Streptomyces sp.177,178 have been corrected from (R) to (S).179,180
Tenacibaculum mesophilum (unidentied sponge, Republic of
Palau) yielded a siderophore bisucaberin B. This is an
open form of the known macrocyclic dimer bisucaberin181,182
that has been reported as a degradation product of
desferrioxamine B183 but not as a product of de novo
biosynthesis.184This journal is © The Royal Society of Chemistry 20153.2 Bacteria from mangroves
Bacillus hunanensis (sediment, Trinity Bay, Galveston Texas,
U.S.A.) yielded hunanamycin A 160, the rst NP with a pyrido
[1,2,3-de]quinoxaline-2,3-dione core, which also displayed
modest inhibition of Salmonella enterica.185Hunanamycin A was
subsequently synthesised via a simple and scaleable method
from 6,7-dimethyl-1,4-dihydroquinoxaline-2,3-dione.186 An
indole alkaloid 161 was obtained from Pantoea agglomerans
(mangrove Ceriops tagal, Zhanjiang, Guangdong, China) along
with two phenylethylamine derivatives, 3-(p-hydroxy)benzoyl
indole187 and 1,2-di(1H-indol-3-yl)ethane,188 both known
synthetic compounds but now isolated for the rst time as





















































































View Article OnlineStreptomyces sp. (mangrove rhizosphere soil Heritiera
globosa, Wenchang, China)190 was the source of a series of
azalomycin F analogues 162–168 which were all broad-spec-
trum antimicrobials and inhibitors of HCT-116 cells.191 The
di-O-prenylated avone 169 was isolated from an endophytic
Streptomyces sp. (mangrove root Myoporum bontioides,
Leizhou Peninsula, Guangdong Province, China) and was a
moderate inhibitor of the plant pathogenic fungi,
Colletotrichum musae, Gibberella zeae and Penicillium
citrinum.192130 | Nat. Prod. Rep., 2015, 32, 116–2113.3 Marine-sourced fungi (excluding from mangroves)
Several acremine metabolites, 5-chloroacremine A 170, 5-
chloroacremine H 171 and acremines O–R 172–175, together
with the known terrestrial fungal metabolite acremine F,193were
isolated from Acremonium persicinum (sponge Anomoianthella
rubra, Gneering Reef, S. E. Queensland, Australia). The cong-
uration of acremine F was determined as 176 and this was the
rst isolation as an MNP.194
Alternaria sp. (sponge Callyspongia sp., Sanya, Hainan Is.,
China) was the source of a variety of meroterpenoids including
tricycloalternarene A 177, the hydrogenated benzofurans, bicy-





















































































View Article Onlinebicycloalternarene E 182 and F 183, and the hydrogenated
cyclopenta-[b]-chromans, tricycloalternarene B 184 and C
185. Four additional monocyclic meroterpenoids mono-
cycloalternarene A195 186 and monocycloalternarene B–D 187–This journal is © The Royal Society of Chemistry 2015189 were obtained when the putative precursors sodium 3,4-
dihydroxybenzoic acid or shikimic acid were fed to the fungus,
reinforcing the proposed shikimate-isoprenoid hybrid biosyn-
thetic pathway. All the metabolites except bicycloalternarenes E
182 and F 183 were weak to moderate inhibitors of NF-kB in
RAW264.7 cells.196
The sesquiterpene ascotrichic acid 190 was isolated from
Ascotricha sp. (coastal mud, Fenghua County, Zhejiang,
China).197 The benzoquinone derivatives aculeatusquinone A–D
191–194 were isolated from Aspergillus aculeatus (sediment,
Langqi Is., Fujian, China) and of these aculeatusquinones B and
D were moderately cytotoxic to several HTCLs.198
An oxepin-containing alkaloid 195, a quinazolinone-con-
taining alkaloid 196 and a dihydrobenzofuran derivative 197
were obtained from A. carneus (brown alga Laminaria sachali-
nensis, Kunachir Is., Russia).199 Clavatustides A 198 and B 199,
cyclodepsipeptides with an unusual anthranilic acid dimer and
a D-phenyllactic acid residue, were isolated from A. clavatus
(hydrothermal vent crab Xenograpsus testudinatus, Kueishantao,





















































































View Article OnlineA. elegans (so coral Sarcophyton sp., Weizhou coral reef, S.
China Sea) produced the phenylalanine derivative 40-methox-
yasperphenamate 200 and the cytochalasins aspochalasin A1
201 and cytochalasin Z24 202, in addition to a number of known
cytochalasin analogues. 40-Methoxyasperphenamate 200 was
modestly active against Staphylococcus epidermidis while the
known cytochalasins aspochalasin I,201 J,201 D202,203 and H204
displayed strong antifouling activity against larval settlement of
the barnacle Balanus amphitrite (B. amphitrite). Aspochalasins I,
J and H, previously isolated from terrestrial Aspergillus species,
are rst time MNPs.205
Of the tris-pyrogallol ethers sydowiol A–C 203–205 from A.
sydowii (sediment, E. China Sea), sydowiols A 203 and C 205
inhibitedM. tuberculosis protein tyrosine phosphatase A (PTPA).206
A. terreus, var. boedijnii (Blochwitz) (red alga Laurencia ceylanica,
Arugam Bay, Sri Lanka) produced a new butyrolactone 206 which
was a strong inhibitor of the enzyme b-glucuronidase.132 | Nat. Prod. Rep., 2015, 32, 116–211A number of known compounds were also isolated which
included (+)-asterrelenin,207 a moderate inhibitor of b-glucu-
ronidase, (3R,4R)-6,7-dimethoxy-4-hydroxymellin208 and (+)-ter-
ritonin A,207 all reported as rst time MNPs.209 The cyclic
tetrapeptide asperterrestide A 207, the alkaloid terremide C 208
and an aromatic butenolide aspernolide E 209 were obtained
from A. terreus (gorgonian Echinogorgia aurantiaca, Sanya,
Hainan Province, China). Asperterrestide A 207 inhibited
inuenza virus strains H1N1 and H3N2 and was cytotoxic to
HTCLs.210
Cultivation of A. unguis (unidentied sponge, Tub-La-Mu
Bay, Pang-nga Province, Thailand) in media containing
diﬀerent halogen salts led to the production of “unnatural
natural” depsidones. Growth in media containing KBr
produced the brominated depsidones aspergillusidone D–F
210–212 and the orcinol derivatives aspergillusidone A 213 and
B 214, whilst culture in KI produced another new depsidone 2,4-
dichlorounguinol 215. Of these, aspergillusidones D–F 210–212
inhibited aromatase, a therapeutic target for breast cancer





















































































View Article OnlineA large number of terpenes were sourced from A. ustus
(green alga Codium fragile, Zhoushan Is., Zhejiang
Province, China) and included the meroterpene 1,2-dihy-
droterretonin F 216, the sesterterpenes (6a)-21-deoxy-
ophiobolin G 217, (6a)-16,17-dihydro-21-deoxyophiobolin G
218, ophiobolins U–W 219–221 and the diasteroisomeric
sesquiterpenes, (6-strobilactone-B) esters of (E,E)-6,7-epoxy-
2,4-octadienoic acids 222 and 223 as new compounds.
Ophiobolin F212 was obtained from the marine environment
for the rst time. Ophiobolin U 219 and the co-isolated
known (5a,6a)-ophiobolin H213 moderately inhibited growth
of E. coli.214
Anthcolorins A–F 224–229, tetrahydropyran diterpene
metabolites containing an oxoindoline moiety were isolated
from A. versicolor (sea urchin Anthocidaris crassispana, Tanabe
Bay, Wakayama, Japan), as three sets of epimeric pairs with
moderate growth inhibition (P388) noted for anthcolorins B–D
225–227.215,216This journal is © The Royal Society of Chemistry 2015Aspeverin 230 isolated from A. versicolor (green alga Codium
fragile, Dalian, China) was a moderate growth inhibitor of the
phytoplankton Heterosima akashiwo.217 Four prenylated
diphenyl ethers diorcinol B–E 231–234 were obtained from A.
versicolor (mud, Yellow Sea),218 of which two, diorcinols D and E
were toxic to HTCLs.219
Endophytic A. wentii (brown alga Sargassum sp., no location
specied) produced wentiquinone A 235, along with another
secoanthraquinone derivative which was claimed as new and
named wentiquinone B. A compound of this structure had
already been isolated as guepinone from the terrestrial fungus
Pestalotiopsis guepinii,220 but this was the rst isolation from the
marine environment.221 The xanthone derivatives yicathin A–C
236–238 were isolated from endophytic A. wentii (red alga
Gymnogongrus abelliformis, Pingtan Is., China). Yicathins B
and C had antimicrobial activities.222
A. westerdijkiae (deep-sea sediment, S. China Sea) was the
source of the benzodiazepine alkaloids circumdatin K 239 and L
240, the prenylated indole alkaloids 5-chlorosclerotiamide 241
and 10-epi-sclerotiamide 242 and the amide aspergilliamide B
243 (ref. 223) whilst Aspergillus sp. (mussel Mytilus edulis,
Toyama Bay, Japan Sea)224 produced himeic acids E–G 244–





















































































View Article OnlineThe cyclic tetrapeptides aspergillipeptide A–C 247–249 and
asteltoxin B 250 were isolated from Aspergillus sp. (gorgonian
Melitodes squamata, Sanya, Hainan province, China) with
aspergillipeptide C 249 showing strong antifouling activity
against Bugula neritina (B. neritina) larvae settlement.226
Aspergillus sp. (sponge Tethya aurantium, Limski canal, N.
Adriatic Sea, Croatia) produced seven new alkaloids, trypto-
quivaline K 251 and fumiquinazolines K–P 252–257, the latter
group containing the rare 1-aminocyclopropane-1-carboxylic
acid residue.227
The prenylated indole alkaloids 17-epi-notoamide Q 258 and
M 259 and the phenyl ether derivative cordyol D 260 were
obtained from Aspergillus sp. (gorgonian Dichotella gemmacea,
Xisha Is., S. China Sea). A further phenyl ether was isolated and
claimed as new but had already been reported from the134 | Nat. Prod. Rep., 2015, 32, 116–211mangrove-associated fungus Penicillium expansum.228 The
synthetic compound dehydronotoamide C229 was obtained for
the rst time as an NP and the fungal metabolite notoamide C230
was also reisolated and the absolute conguration previously
proposed231 for this metabolite proven as 261.232 As a conse-
quence the congurations of the Aspergillus-derived notoamides
J,233 Q234 and M,235 have been corrected from (3S) to (3R) for
notoamide J235,236 and from (3R) to (3S) for notoamides Q and
M.237,238
Aspergillide D 262, a 16-membered macrolide, was isolated
from Aspergillus sp. (gorgonian Melitodes squamata, Sanya,
Hainan Province, China).239 Co-isolated were two known ses-
quiterpenoid nitrobenzoyl esters, 9a,14-dihydroxy-6b-p-
nitrobenzoylcinnamolide240 and 7a,14-dihydroxy-6b-p-nitro-
benzoylconfertifolin,240 moderate inhibitors of H1N1.239
Two aspergillic acid group toxins aspergilliamide 263 and
ochratoxin A butyl ester 264 were obtained from Aspergillus
sp. (gorgonian Melitodes squamata, Sanya, Hainan Province,
China), both modestly toxic to brine shrimp (Artemia salina).
Co-isolated was the known neoaspergillic acid241 and,
surprisingly, the aluminium and zirconium salts of the
acid.242
A racemic mixture of a g-lactone derivative 265 was isolated
from Aspergillus sp. (gorgonian Melitodes squamata, Sanya,
Hainan Province, China) with signicant toxicity to brine
shrimp.243 A lactam derivative was also obtained and the
structure proposed as a dehydrated pyrrolyl 1-isoquinoline
alkaloid,243 a structure originally proposed for marinamide, but
which was subsequently revised to that of the dehydrated
quinoline alkaloid penicinoline (in section 3.4 below this same
problem is addressed with respect to two unidentied micro-
organisms grown in co-culture).244,245 While it might be possible
that these two compounds have very similar NMR data, X-ray
crystallography of this new marinamide is required to resolve
the doubt.
Bartalinia robillardoides (sponge Tethya aurantium, Limsky
Channel, Croatia) was the source of the chloroazaphilone heli-
cusin E 266 and the pentaketide bartanolide 267. Iso-
chromophilones X246 and XI246 were also isolated and claimed as
new but are known terrestrial fungal metabolites. Iso-
chromophilone XI,246 along with other known fungal metabo-
lites helicusin A247 and deacetylsclerotiorin,248 had a variety of
moderate to weak antimicrobial activities.249
Calcarisporium sp. (seawater, Wadden Sea, Germany) gener-
ated macrocyclic and linear polyesters including calcarides A–E
268–272, out of which calcarides A–C 268–270 and the co-iso-
lated analogues 15G256a and 15G256b, previously obtained
from the marine fungus Hypoxylon oceanicum,250 inhibited
growth of Staphylococcus epidermidis and Xanthomonas cam-
pestris while the linear ester 15G256p inhibited growth of Pro-
pionibacterium acnes.251
Two lanostanes 273 and 274, with the latter previously
reported in the patent literature as a metabolite of the mush-
room Fomitopsis pinicola,252 were obtained from endophytic
Ceriporia lacerate (starsh Acanthaster planci, Hainan Sanya
National Coral Reef Reserve, China).253 Although a further lan-





















































































View Article Onlinewas also claimed as new, it had previously been isolated from a
fungal endophyte of a traditional Chinese medicinal plant
Huperzia serrata.254This journal is © The Royal Society of Chemistry 2015Chondrostereum sp. (so coral Sarcophyton tortuosum,
Hainan Sanya National Coral Reef Reserve, China), previously
the source of chondrosterins A–E,255 produced further chon-
drosterins F–H 275–277. The terrestrial fungal metabolites
incarnal256 and arthrosporone,257 and the plant metabolite (2E)-
decene-4,6,8-triyn-1-ol,258 were also all isolated for the rst time
as MNPs.259 The benzolactone metabolites chrysoarticulin A–C
278–280 were isolated from Chrysosporium articulatum,
(unidentied dictyoceratid sponge, Gagu-do, S. Korea) with
chrysoarticulin C 280 active against the bacterial transpeptidase





















































































View Article OnlineDendrodochium sp. (sea cucumber Holothuria nobilis, S.
China Sea) produced the 12-membered macrolides den-
drodolide A–M 281–293 (dendrodolides A–E, G–I, K and L had136 | Nat. Prod. Rep., 2015, 32, 116–211modest inhibitory activity against two HTCLs),261 while the
polyketides 294 and 295 were obtained from Eutypella scoparia
(sediment, S. China Sea).262
Gymnascella dankaliensis (sponge Halichondria japonica,
Osaka Bay, Japan)263 provided dankastatin C 296, a polyketide
tyrosine derivative with potent growth inhibition of P388
cells.264 Hypocreales sp. (sponge Gelliodes carnosa, S. China Sea)
was the source of the cadinane-type sesquiterpenes hypo-
createrpene A 297 and B 298. The known terrestrial plant
metabolites, (1R,6R,7R,10S)-10-hydroxy-4(5)-cadinen-3-one265
and (R)-5,6-dihydro-6-pentyl-2H-pyran-2-one266 were also iso-
lated for the rst time as MNPs and both had moderate anti-
inammatory activity (inhibition of NO production).267 Oxir-
apentyn E 299, a highly oxidised chromene was isolated from
Isaria felina (sediment, Vietnam) as a growth stimulant of corn





















































































View Article OnlineMetarhizium anisopliae (unidentied sponge, Naozhou Is.,
Guangxi, China) generated two naphtho-g-pyrone glycosides
indigotide G 300 and H 301. The known compounds iso-
chaetochromin B2 (ref. 269) and ustilaginoidin D270 were
obtained for the rst time from a marine source and displayed
modest inhibition of Mycobacterium phlei.271
Sartorypyrone B 302, a moderate inhibitor of HTCLs, was
obtained from Neosartorya tsunodae (sponge Aka cor-
alliphaga, Similan Is., Phagna Province, Thailand),272 while
tryptoquivalines R 303 and S 304 are indole alkaloids
obtained from Neosartorya sp. (intertidal mud, Hainan
Province, China),273 previously the producer of tryptoquiva-
lines P and Q.274
Paecilomyces sp., (unspecied sponge, Tinggi Is., Malay-
sia) was the source of the dione 305,275 while the chryso-
triazoles A 306 and B 307 were obtained from endophytic
Penicillium chrysogenum (brown alga Sargassum palladium,
Fujian, China).276 P. oxalicum (sediment, Bohai Bay, Liaoning
Province, China) produced decaturins E 308 and F 309,277
and 2-(4-hydroxybenzoyl) quinazolin-4(3H)-one 310 was
isolated from P. oxalicum (strain 0312F1, Genbank accession
no. EU926977) as a moderate inhibitor of tobacco mosaic
virus (TMV) and the human gastric cancer cell line
SGC-7901.278This journal is © The Royal Society of Chemistry 2015The dihydrothiophene-condensed chromones oxalicumone
A 311 and B 312 were obtained from P. oxalicum (gorgonian
Muricella exuosa, Sanya, China) with oxalicumone A 311
moderately cytotoxic to HTCLs.279 A further chromone was also
claimed as new and named as oxalicumone C but while isolated
from a natural source for the rst time, is a known reaction
product of chloromonilicin, a metabolite of the cherry rot
fungus Monilinia fructicola.280
The anthranilic acid derivatives penipacid A–C 313–315, E
316 and G 317 were isolated from P. paneum (sediment, S.
China Sea) together with a known analogue, 2-[(1-methyl-2-
oxopropylidene)aminobenzoic acid,281 previously syn-
thesised but now isolated as an NP. Penipacids A 313 and
E 316 inhibited human colon cancer RKO cells and
2-[(1-methyl-2-oxopropylidene)aminobenzoic acid was cyto-
toxic to HeLa cells.282
P. pinophilum (sediment, Pearl River Estuary, S. China Sea)
yielded pinodiketopiperazine A 318 and 6,7-dihydroxy-3-





















































































View Article Onlinecompounds, alternariol 2,4-dimethyl ether283,284 and L-5-oxo-
proline methyl ester285 as rst time NPs. The phthalide 319
displayed potent cytotoxicity to brine shrimp and pinodiketo-
piperazine A 318, alternariol 2,4-dimethyl ether283,284 and the co-
isolated known metabolites N-methylphenyldehydroalanyl-L-
proline-anhydride286 and rubralide C287 all exhibited moderate
inhibition of E. coli growth.288
The chlorinated sesquiterpenoid ligerin 320 came from a
Penicillium strain (seawater, La Pre´e, Loire Atlantique, France)
and strongly inhibited the osteosarcoma cell line POS1,289 while
another Penicillium sp. (sediment, Jiaozhou Bay, China) yielded
prenpenicillide 321 and prenxanthone 322.290
The polyaromatic metabolites herqueiazole 323, herqueiox-
azole 324 and herqueidiketal 325 were obtained from Penicil-
lium sp. (sediment, Gagu-do, S. Korea). Herqueidiketal 325 was
moderately cytotoxic to A549 cells and signicantly inhibitory
against sortase A.291 Penicillium sp. (gorgonian Dichotella gem-
macea, Sanya, Hainan Province, China) produced the indolyl
diketopiperazine penilloid A 326 in addition to a number of
known indole alkaloids.138 | Nat. Prod. Rep., 2015, 32, 116–211Aspergillus sydowii (gorgonian Verrucella umbraculum,
Sanya, Hainan Province, China) also yielded additional
known indole alkaloids including fumiquinazoline D,292
cyclotryprostatin B293 and fumiquinazoline G,294 which in
addition to (E)-3-(1H-imidazol-4-ylmethylene)-6-(1H-indol-3-
ylmethyl)-2,5-piperazinedione,295 meleagrin,296 roquefortine
C,297 and 11a-methoxy roquefortine C298 from the Penicillium
sp. exhibited signicant antifouling activity towards
B. amphitrite and/or B. neritina larvae. Meleagrin also exhibi-
ted moderate activity against the larvae settlement-inducing
bacterium Micrococcus luteus.299 Penstyrylpyrone 327 and the
known terrestrial fungal metabolite anhydrofulvic acid (rst
time MNP)300 were obtained from Penicillium sp. (unidentied
sponge. Jeju Is., S. Korea) as inhibitors of protein tyrosine
phosphatase 1B (PTP1B) activity. Furthermore, penstyrylpyr-
one 327 suppressed production of pro-inammatory media-
tors via the NF-kB pathway through expression of the anti-
inammatory enzyme, heme oxygenase.301
Penicillium sp. (gorgonian coral Dichotella gemmacea, Sanya,
Hainan, China) was the source of the polyketides 328 and
paecilin C 329, and some known analogues. 6,8,50,60-Tetrahy-
droxy-30-methylavone 328, emodin,302 citreorosein302 and iso-
rhodoptilometrin303 exhibited signicant antifouling activity
against B. amphitrite larvae settlement while penicillixanthone
A304 was moderately antibacterial.305
Endophytic Penicillium sp. (unidentied sponge, Weizhou, S.
China Sea) was the source of the hydroisocoumarins pen-
icimarin A–C 330–332, the isocoumarins penicimarin D–F 333–
335 and the benzofurans penicifuran A–D 336–339, out of which
only penicifuran A 336 was cytotoxic to Staphylococcus albus





















































































View Article OnlineCo-cultivation of Penicillium sp. (sponge Mycale angulosa,
Toque-Toque Is., Brazil)307 and Trichoderma sp. (sponge Geodia
corticostylifera, same location)307 led to the unusual polyketides,
(Z)-2-ethylhex-2-enedioic acid 340 and (E)-4-oxo-2-propylideneoct-
7-enoic acid 341.308 A chloro-trinoreremophilane sesquiterpene
342 and three chlorinated eremophilane sesquiterpenes 343–
345 were isolated from Penicillium sp. (deep-sea sediment,
Prydz Bay, Antarctica). Just 342 was cytotoxic to HTCLs
(moderate).309
The isoaustamide alkaloid 346 was obtained from Penicil-
lium sp. (unidentied sponge, Jeju Is., S. Korea). Also isolated
for the rst time as an NP was deoxydihydroisoaustamide,
previously reported as an intermediate in the total synthesis of
(+)-deoxyisoaustamide.310,311 Pestalotiopsis sp. (so coral Sar-
cophyton sp., Yongxing Is., S. China Sea) was the source of the
chlorinated benzophenone derivative ()-pestalachloride D 347
(moderate antibacterial activity against several Gram-positive
strains). Co-isolated was ()-pestalachloride C, known as aThis journal is © The Royal Society of Chemistry 2015metabolite of terrestrial endophytic Pestalotiopsis adusta312 but
now a rst time MNP.313
The eudesmane sesquiterpenes 348 and 349 were
produced by Pestalotiopsis sp. (brown alga Sargassum
horneri, Wenzhou, China) in response to abiotic stress elici-
tation by addition of CuCl2 to the growth media and both
were both potent inhibitors of tyrosinase.314 Endophytic
Phaeosphaeria spartinae (red alga Ceramium sp., North Sea,
Bu¨sum, Germany) was the source of spartopregnenolone
350.315
Polyporapyranones A–H 351–358 were isolated from two
Polyporales species (seagrass Thalassia hemprichii, location
unspecied, presumably Thailand). Polyporapyranones A
351 and D 354 exhibited moderate and weak inhibition
of the Vero cell line respectively.316 Scopulariopsis sp.
(gorgonian Carijoa sp., Weizhou, S. China Sea) was the source
of fumiquinazoline L 359, an alkaloid with a heptacyclic





















































































View Article OnlineStachybotrys chartarum (sponge Xestospongia testudinaris,
Xisha Is., China) yielded new phenylspirodrimanes stachybotrin
D–F 360–362, stachybocin E 363 and F 364 and stachyboside A
365 and B 366, of which stachybotrin D 360 inhibited replica-
tion of HIV-1 by targeting reverse transcriptase and blocked
non-nucleoside reverse transcriptase inhibitors-resistant
strains as well. The absolute conguration of a co-isolated
known terrestrial sesquiterpenoid 367 (S. chortarum318) was
determined.319
Several polyketides were obtained from Stachylidium sp.
(sponge, Callyspongia sp. cf. C. ammea, Bear Is., Sydney, Aus-
tralia) including cyclomarinone 368, maristachone A–E 369–373140 | Nat. Prod. Rep., 2015, 32, 116–211and marilactone.320 Due to rotation values being close to zero,
racemic mixtures were assumed for cyclomarinone 368, mari-
stachone A 369 and the epimers 372 and 373. Marilactone320 is a
known synthetic compound but now a rst time NP. From a
biosynthetic perspective, all of the isolated compounds are
unusual due to the presence of an additional carbon atom over
the basic polyketide skeleton.321Stagonosporopsis cucurbitacearum (unidentied sponge,
Atami-shi, Shizuoka Prefecture, Japan) yielded the alkaloids
didymellamides A–D 374–377. Didymellamide A 374 inhibited
growth of several pathogenic fungi including azole-resistant C.
albicans.322
The peptaibols aspereline G 378 and H 379 were obtained
from Trichoderma asperellum (sediment, Langqi Is., Fujian,
China),323 while asperelines G-Z13 are thirty-two new short
peptaibols detected from T. asperellum (sediment, Penguin Is.,
Antarctica) by ultrahigh pressure liquid chromatography in





















































































View Article Onlinespectrometry (UHPLC-ESIMS/MS).324 Several strains of marine-
derived T. atroviride (University of Nantes culture collection)
produced two series of 17-residue peptaibiotics with a common
C-terminus325 and eight new peptaibols 380–387, trichorzianine
1938, 1909, 1895, 1896, 1924, 1910, 1924A and 1909A, linear 19-
residue hydrophobic peptides were obtained from T. atroviride
(Axinellid sponge, Akhziv, Mediterranean coast, Israel).326
The diterpenoid lactone trichodermaerin 388 was isolated
from endophytic T. erinaceum (sea star Acanthaster planci,
Hainan Sanya National Coral Reef Reserve, China).327 A Xylar-
iaceae sp. (gorgonian coral Melitodes squamata, S. China Sea)
produced a number of polyketides including penicitrinol F 389,
7-carboxypenicitrinol C 390 and 391–393. Several known poly-
ketides were also isolated and of these, dihydrocitrinin328 andThis journal is © The Royal Society of Chemistry 2015phenol acid A328 strongly inhibited settlement of B. neritina
larvae with dihydrocitrinin328 also an inhibitor of the enzymes
SHP2 and IMPDH. Phenol acid A328 and dihydrocitrinone329
inhibited cathepsin B and (3R,4S)-(+)-4-hydroxy-6-deoxyscyt-
alone330 inhibited the enzymes SHP2, PTP1B and IMPDH and
is a rst time MNP.331 There is considerable confusion
surrounding this report: the name penicitrinol F has been given
previously to a citrinin derivative obtained from a Penicllium
sp.332 so 389 should be renamed. Also, for 7-carboxypenicitrinol
C 390 there is a discrepancy between the conguration in the
diagram and in the text. The text gives (1R) but the diagram
gives (1S). If the diagram is correct, this is a known compound
from both terrestrial333 and marine334,335 fungi. The congura-





















































































View Article Onlinethe gorgonian-derived fungus Cochliobolus lunatus336 has been
corrected to 394.337
Addition of sodium bromide to a culture of Aspergillus
ochraceus (red alga Chondria crassicualis, Yokji Is., Kyeongnam
Province, S. Korea) resulted in medium-induced production of
(R)-()-5-bromomellein as a modest radical scavenger (against
1,1-diphenyl-2-picrylhydrazyl (DPPH)). Both the racemate338 and
antipode339 have been previously synthesised but this is the rst
report of their isolation as NPs.340 The sesquiterpene helmin-
thosporic acid has been reported previously as a semi-synthetic
derivative of the fungal metabolite helminthosporol aldehyde341
but has been isolated for the rst time as an NP from Drechslera
sp. (green alga Ulva sp., To¨nning, North Sea).342 Also as a rst
time MNP was the terrestrial fungal metabolite epiepoformin343
isolated from an endophytic Penicillium sp. (brown alga Fucus
spiralis, Bridge End, Shetland Is., U.K.).3443.4 Fungi from mangroves
Aspergillus eﬀuses (rhizosphere soil, unidentied mangrove,
Fujian Province, China) produced the prenylated indole diketo-
piperazine alkaloid dihydroneochinulin B 395 and the enantio-
meric spiro-polyketide-diketopiperazine hybrids cryptoechinuline
D 396 and 397. The latter compound has been isolated previously
from terrestrial345 and marine346 fungi but in this study was
resolved into enantiomers and absolute congurations
assigned.347 The benzyl derivatives aspergentisyl A 398 and
aspergentisyl B 399 and a naphthoquinone derivative aspergio-
diquinone 400 were isolated from A. glaucus (mangrove sediment,
unspecied species, Fujian Province, China). Aspergentisyls A 398
and B 399 were strong radical-scavengers (DPPH).348142 | Nat. Prod. Rep., 2015, 32, 116–211Some 4-phenyl-3,4-dihydroquinolone derivatives were
obtained from A. nidulans (mangrove leaves Rhizophora stylosa,
source not given, presumably China), namely aniduquinolone
A–C 401–403, 6-deoxyaaquinolone E 404, isoaaquinolone E
405 and 14-hydroxyaaquinolone F 406. Of these, aniduquino-
lones B 402 and C 403 and the co-isolated aaquinolone A349
were moderately toxic to brine shrimp. Aaquinolone A, previ-
ously obtained from a terrestrial Aspergillus sp., was obtained
for the rst time as an MNP.350
Aniquinazolines A–D 407–410 are quinazolinone alkaloids
from the endophytic A. nidulans (mangrove leaves Rhizophora
stylosa, unspecied location, presumably China) and were all
strongly cytotoxic to brine shrimp.351 The nigerasterols A 411





















































































View Article OnlineAvicennia marina, Hainan, China) as relatively potent inhib-
itors of the HTCLs HL60 and A549.352 The butenolide iso-
aspulvinone E 413 came from A. terreus (mangrove
rhizospehere soil, Fujian Province, China) along with the
known butenolides aspulvinone E353 and pulvic acid.354 All
exhibited signicant H1N1 virus inhibition but only iso-
aspulvinone E inhibited H1N1 viral neuraminidase. Pulvic
acid was a rst time MNP.355
A. taichungensis (mangrove root soil Acrostichum aureum, no
location given)356 was the source of the prenylated indole alka-
loids 6-epi-stephacidin A 414, N-hydroxy-6-epi-stephacidin A 415
and 6-epi-avrainillanide 416, and of these 415 and 416 were
cytotoxic to two HTCLs. On exposure to light and air 415 con-
verted to a complex mixture of analogues, including (+)-versi-
colamide B,357 a mixture of two compounds (here named
versicolamide C) and 416, which suggested that 416 may be an
artefact. 6-Epi-stephacidin A 414 was stable under the same
conditions.358
Botryosphaerin F 417 was obtained from endophytic A.
terreus (mangrove branch Bruguiera gymnorhiza, Guangxi,
China) and inhibited growth of HTCLs.359 Several known
compounds were also isolated including LL-Z1271b,360 whichThis journal is © The Royal Society of Chemistry 2015although reported as active against the HL60 cell line used
here, had previously been reported as being inactive against a
number of other HTCLs.361,362 Endophytic A. terreus
(mangrove branch Bruguiera gymnorhiza, Guangxi province,
China) was the source of a thiophene compound 418. The co-
isolated 6-ethyl-5-hydroxy-3,7-dimethoxynaphthoquinone,363
a known synthetic compound, was a rst time NP.364 Asper-
terpenoid A 419, a sesterterpenoid with a new carbon
skeleton, was isolated from endophytic Aspergillus sp.
(mangrove species not specied, no location given) and dis-
played inhibitory activity against M. tuberculosis protein
tyrosine phosphatase B (mPTPB).365 Asperterpenols A 420 and
B 421 are sesterterpenoids with an unusual 5/8/6/6 tetracyclic
ring skeleton. Both were acetylcholinesterase inhibitors and
were obtained from endophytic Aspergillus sp. (mangrove,
S. China Sea).366
Cladosporium sp. (mangrove soil, Guangzhou, China) was
the source of a number of indole alkaloids including ve
glyantrypine derivatives; 3-hydroxyglyantrypine 422, oxo-
glyantrypine 423, 424, cladoquinazoline 425 and epi-clado-
quinazoline 426 and a pyrazinoquinazoline derivative
norquinadoline A 427. Of these alkaloids, oxoglyantrypine
424 and norquinadoline A 427, together with the co-isolated
known terrestrial Aspergillus alkaloid metabolites, deoxy-
nortryptoquivaline,367 deoxytryptoquivaline,367 tryptoquiva-
line368 and quinadoline B369 had signicant activities against
H1N1. The latter four were also obtained for the rst time as
MNPs. Over time, a solution of oxoglyantrypine 423 partially
converted into 424, leading to the proposal that 424 was an





















































































View Article OnlineFurther investigation of endophytic Corynespora cassiicola
(mangrove leaf Laguncularia racemosa, Hainan Is., China),
which originally yielded some decalactone derivatives,371 yiel-
ded some minor metabolites coryoctalactone A–E 428–432, of
which coryoctalactones A 428 and B 429 were assumed to be C-9
epimers.372
As part of a screening programme for new antimalarial
compounds, four metabolites were obtained from several
species of Chinese mangrove endophytic fungi from either Mai
Po Nature Reserve, Hong Kong or Hainan Is., Taiwan. Despite
lack of a tight correlation between location and source micro-
organism, this study described the isolation of a dimeric144 | Nat. Prod. Rep., 2015, 32, 116–211tetrahydroxanthone dicerandrol D 433 from a Diaporthe sp.,
diaporthochromes A 434 and B 435 from another Diaporthe sp.
and the lipid 436 was obtained from Xylaria sp. Dicerandrol D
433 exhibited potent activity against P. falciparum with relatively
low toxicity to A549 cells.373
Endophytic Fusarium proliferatum (mangrove Bruguiera





















































































View Article Onlinesesterterpenes fusaprolin A 437 and B 438 and the
2H-pyran-2-one derivatives prolipyrone A–C 439–441.
Fusaprolins A and B had modest activity against brine
shrimp.374
Penicillium camemberti (mangrove soil Rhizophora apiculata,
Wenchang, Hainan Province, China) produced the indole
diterpenoids 442–447, as well as some known analogues. Of
these, emindole SB,375 21-isopentenylpaxilline,376 paspa-
line,377,378 and paxilline379 displayed signicant activity against
H1N1 as did indole diterpenoids 442–444, 446 and 447. 21-
Isopentenylpaxilline376 and dehydroxypaxilline380 were obtained
for the rst time as MNPs.381
Penicillium sumatrense (mangrove rhizosphere Lumnitzera
racemosa, WenChang, Hainan Is., China) yielded sumalarins
A–C 448–450, sulfur-containing curvularin derivatives
which were cytotoxic to several HTCLs.382 The planar
structure of sumalarin C 450 had previously been
reported as part of several compound libraries.383–385 The
citrinin dimers penicitrinone E 451 and penicitrinol J 452
and the citrinin monomers penicitrinol K 453 and
citrinolactone D 454 were isolated from Penicillium sp.
(mangrove sediment, Fu Gong, Long Hai, Taiwan Strait,
China).386This journal is © The Royal Society of Chemistry 2015Arisugacin I 455, an a-pyrone meroterpene, was obtained
from endophytic Penicillium sp. (mangrove leaves Kandelia
candel, Shankou, Guangxi Province, China) as an inhibitor of
acetylcholinesterase.387 The known fungal metabolite arisuga-
cin F388 was also obtained for the rst time from the marine
environment.387 Endophytic Penicillium sp. (mangrove leaves
Avicennia sp., Dong Sai, Hainan, China) yielded the iso-
benzofuranone 456 which was moderately cytotoxic to KB and
KBV200 cells.389
Pestaliopens A 457 and B 458, hybrid sesquiterpene–cyclo-
paldic acid metabolites with an unusual carbon skeleton, were
isolated from endophytic Pestalotiopsis sp. (mangrove leaves
Rhizophora mucronata, Hainan Is. China). Pestaliopen A 457
exhibited modest inhibition of E. faecalis.390
P. virgatula (mangrove leaf Sonneratia caseolaris, Dong Zhai
Gang mangrove garden, Hainan Is., China) yielded the a-pyrone





















































































View Article Onlinehydroxypestalotin 463,391 a diastereoisomer of a metabolite
isolated from a plant associated Penicillium sp.392
The xanthones O-glycoside 464 isolated from endophytic
Phomopsis sp. (mangrove stem Excoecaria agallocha, Dong Zai,
Hainan, China)393 and 465 and 466 isolated from Phomopsis sp.
(mangrove sediment, Shankou, Hainan, China)394,395 were
moderate inhibitors of HEp-2 and HepG2 cells.146 | Nat. Prod. Rep., 2015, 32, 116–211Three new phomoxanthone compounds phomolactonex-
anthone A 467, B 468 and deacetyl-phomoxanthone C 469 were
obtained from Phomopsis sp. (mangrove branch Acanthus
ilicifolius, Hainan, S. China Sea) along with ve phomoxanthones
known as endophytic metabolites of terrestrial fungi, namely
dicerandrol A,396 dicerandrol B,396 dicerandrol C,396 deacetylpho-
moxanthone B397 and penexanthone A,398 all isolated as rst time
MNPs.399Phomopsis sp. (mangrove plant Rhizhopora mucronata, Muara
Angke, Jakarta, Indonesia) was the producer of the dimeric
tetrahydroxanthone 12-O-deacetyl-phomoxanthone A 470 which
exhibited moderate inhibition of several Gram-positive
bacteria.400 A polysubstituted benzaldehyde derivative 471 was
isolated from co-culture of two unidentied mangrove fungi (S.
China Sea coast).401
Marinamide and the methyl ester, methyl-marinamide were





















































































View Article Onlineendophytic fungi from the S. China Sea Coast and assigned as
pyrrolyl 1-isoquinolone alkaloids.402 Subsequently, the fungus
Auxarthron reticulatum (sponge Ircinia variabilis) yielded the
quinolinone methyl-penicinoline, shown to be identical to
methyl-marinamide requiring structural revision.244 The revised
structure of marinamide is identical to that of penicinoline,
previously obtained from a mangrove endophytic fungus.403
This problem has already been addressed above in Section 3.3.
Both marinamide/penicinoline403 and its methyl ester245 dis-
played potent cytotoxicity to several HTCLs.3.5 Cyanobacteria
There has been a marked drop in the number of new metabo-
lites reported from cyanobacteria, continuing the downward
trend from 2012. The lipopeptide malyngamide 4 472 was iso-
lated from Moorea producens (Red Sea, Jeddah, Saudi Arabia) as
a moderate inhibitor of several HTCLs.404
M. producens (La Parguera, Puerto Rico) was the source of the
lipopeptides parguerene 473 and precarriebowmide 474.
Studies of the stability of precarriebowmide 474 to atmospheric
oxygen indicated that carriebowmide405 and carriebowmide
sulfone,406 previously isolated from Lyngbya polychroa and
Lyngbya majuscula respectively, may in fact be isolation artefacts
of precarriebowmide 474.407
Two new aprataoxin analogues, apratoxin H 475 and apra-
toxin A sulfoxide 476, were obtained from M. producens, (Nabq
Mangroves, Gulf of Aqaba, Red Sea) and both exhibited cyto-
toxicity to NCI-H460 lung cancer cells, but apratoxin H 475 was
much more potent than apratoxin A sulfoxide 476.408
M. bouillonii (New Britain, Papua New Guinea) was the
source of bouillonamide 477, a cyclic depsipeptide which con-
tained two unique polyketide-derived moieties, a 2-methyl-6-
methylamino-hex-5-enoic acid residue and a unit of 3-methyl-5-
hydroxy-heptanoic acid. Bouillonamide 477 displayed moderate
toxicity to neuron 2a mouse neuroblastoma cells.409This journal is © The Royal Society of Chemistry 2015A cyanobacterium of similar morphology to Lyngbya sp. (Piti
Bay, Guam) produced the lipids pitinoic acid A 478 and B 479.
Pitinoic acid A 478 inhibited quorum sensing in Pseudomonas
aeruginosa and pitinoic acid B 479 exhibited anti-inammatory
activity, inhibiting production of pro-inammatory cytokine
expression. Pitinoic acid B 479 has been synthesised.410 A
species resembling the genus Symploca (Santa Cruz Is., Coiba
National Park, Panama) yielded santacruzamate A 480, a potent
and specic inhibitor of histone deacetylase 4 and cytotoxic to
several HTCLs. Santacruzamate A 480 was synthesised from g-
aminobutyric acid.411
3.6 Dinoagellates
An Amphidinium sp. (sediment, Iriomote Is., Japan) was the





















































































View Article Onlinemoderate cytotoxicity against human B lymphocyte DG-75
cells.412An epoxy polyether with twelve contiguous trans-fused ether
rings, gambieroxide 483 was obtained from Gambierdiscus tox-
icus (Papeete, Tahiti, French Polynesia).413 Gymnocin-A2 484
was isolated from Karenia (formerly Gymnodinium) mikimotoi
(Kushimoto Bay, Wakayama, Japan) as a moderate cytotoxin to
P388 cells, along with the known synthetic analogue, gymnocin-
A carboxylic acid414 (rst isolation from a natural source).415
The epiphytic, benthic dinoagellate Ostreopsis cf. ovata (Jeju
Is., S. Korea) was the source of ostreol A 485, signicantly
cytotoxic to brine shrimp,416 whilst the IK2 strain of O. ovata148 | Nat. Prod. Rep., 2015, 32, 116–211(Ikei Is., Okinawa, Japan) produced ovatoxins-a, -d and -e, each
tentatively assigned by negative fast-atom bombardment colli-
sion-induced tandem mass spectrometry (FAB CID MS/MS).417Pyrocystis lunula (University of Texas Culture Collection)
yielded three polyunsaturated C27 hydrocarbons; n-hepta-
cosa-3,6,9,12,15,18-hexaene (C27:6) 486, (approx. 0.7 ng
per sheathed cell), n-heptacosa-3,6,9,12,15,18,21-heptaene
(C27:7) 487 and n-heptacosa-3,6,9,12,15,18,21,24-octaene
(C27:8) 488.418 The benthic dinoagellate Vulcanodinium
rugosum (Northland, New Zealand) yielded portimine 489, a
polycyclic ether toxin containing a ve-membered imine ring,
which exhibited potent toxicity to P388 cells, in addition to





















































































View Article OnlineThe structure of amphidinolide N, the most potent cytotoxic
macrolide isolated from Amphidinium sp. to date420 has been
revised to 490 (and the relative conguration has been
assigned).421
3.7 Microalgae
The microalga Nannochloropsis granulata (Provasoli-Guillard
National Centre for Culture of Marine Phytoplankton, West
Boothbay Harbour, Maine) was the source of the digalacto-
syldiacylglycerols 491, 492 and the known 493 (ref. 422) and
494,422 whose congurations were determined. Also isolated
were the monogalactosyl analogues 495,422 496 (ref. 423)
(rst time as an NP) and 497.423 All of the isolated
metabolites exhibited strong NO inhibitory activity against
LPS-induced NO production in RAW264.7 macrophage cells
suggesting potential as anti-inammatory agents.424 The
green microalga Tetraselmis sp. (National Institute of Tech-
nology and Evaluation Biological Resource Centre, Chiba,
Japan) was a producer of the glycosylceramides GT1 498 and
GT2 499.425This journal is © The Royal Society of Chemistry 20153.8 Synthetic aspects
Synthesis of acremolin, originally isolated from sponge-
associated Acremonium strictum and assigned as containing a
1H-aziridine moiety426 proved that the alternative structure
independently proposed (an isomeric, substituted N2,3-
ethenoguanine)427 was indeed correct.428 Total synthesis of
ent-()-azonazine utilising a hypervalent iodine-mediated
biomimetic oxidative cyclisation to construct the core, has
resulted in revision of the absolute conguration of natural
(+)-azonazine, originally obtained from Hawaiian Aspergillus
insulicola429 to 500,430 while syntheses of versicolactones A
and B, lactones originally isolated from coral-associated
Aspergillus versicolor,431 have resulted in revision of the
absolute congurations of the NPs to (4Z,6R,7S)-501 and
(4E,6R,7S)-502 respectively.432 It should be noted that the
names versicolactones A and B have also been used to refer to
unrelated sesquiterpene lactones isolated from the plant
Aristolochia versicolor.433,434
Citrinadins A and B are pentacyclic alkaloids, originally
obtained from a red alga-associated strain of Penicillium cit-
rinum.435,436 An enantioselective total synthesis of ()-citrinadin
A has been achieved in twenty steps from commercially avail-
able materials which featured an asymmetric vinylogous Man-
nich addition of a dienolate to a chiral pyridinium salt to set the
initial chiral centre. The synthesis led to revision of the core
stereochemistry of the citrinadins and thus of citrinadin A to
503.437 An enantioselective total synthesis of (+)-citrinadin B
featuring a stereoselective intermolecular nitrone cycloaddition
reaction as a key step, similarly led to revision of the congu-





















































































View Article OnlineTrichodermatide A, a polyketide isolated from the fungus
Trichoderma reesei,439 has been synthesised from L-tartaric acid
utilising an intramolecular ketal formation reaction to
construct the core of the molecule.440 The total syntheses of the
putative structures of ()-trichodermatides B and C featuring
the oxa-[3 + 3] annulation strategy have also been accomplished
but mismatch of spectroscopic data between the synthetic and
NP samples has indicated that the structural assignments of
these metabolites may need revision.441 Syntheses of two dia-
stereoisomers of penicillenol C1, originally obtained from an
endophytic, mangrove-associated Penicillium species,442 have
led to reassignment of the absolute conguration as 505
(5S,6R,9S).443 The absolute congurations of the endophytic
mangrove Pestalotiopsis sp. metabolites, pestalotiopsones D and
E444 were determined through total syntheses as 506 and 507
respectively.445
Synthesis of the reported structure of xylopyridine A, a DNA-
binding agent originally obtained from a mangrove-associated
Xylaria sp.,446 has indicated that the reported structure is
incorrect and requires revision.447 Total synthesis of laxaphycin150 | Nat. Prod. Rep., 2015, 32, 116–211B, a metabolite of terrestrial Anabaena laxa448 and of marine L.
majuscula,449 was achieved through stepwise automated solid-
phase peptide synthesis, which led to revision of conguration
to 508. The related L. majuscula metabolite lyngbyacyclamide
A450 was also synthesised by a similar procedure.451
The dolastatin 14 analogue, malevamide E, was originally
obtained from the cyanobacterium Symploca laete-viridis and
the stereochemistry of the peptidic portion assigned.452
Convergent synthesis of (29S,37S)-malevamide E involving Julia-
Kocienski olenation, Urpi acetal aldol and Shiina macro-
lactonisation reactions has been achieved but a mismatch of
the NMR data between the synthetic and natural samples
indicated that the originally assigned congurations of some of
the amino acids need revision.453 A stereoselective synthesis of
the C-43–C-67 fragment of amphidinol 3, originally obtained
from the dinoagellate Amphidinium klebsii,454 revised the
originally assigned conguration at C-51 from (R) to (S).455 Ieo-
domycins A and B are antimicrobial fatty acids originally
obtained from a Bacillus sp.456 The rst457 of several total
syntheses of these published in 2013,458–460 has been achieved in
een steps via the chiral pool approach from D-glucose.457
Syntheses of the glycolipopeptides ieodoglucomide A and B,
originally obtained from Bacillus licheniformis,461 have been
accomplished via a method involving b-glycosylation and
Grubbs olen cross-metathesis as key steps. The syntheses
highlighted that the optical rotation values were originally
misreported as being of opposite sign to their actual values and
the authors of the isolation paper had noted this also.462,463
Syntheses of marinacarbolines A–D, antimalarial b-carboline
alkaloids originally obtained from Marinactinospora thermoto-
lerans464 were achieved in four steps from methyl 1-chloro-b-
carboline-3-carboxylate465 and the cyclic peptide urukthapel-
statin A, originally isolated from the bacterium Mecherchar-
imyces asporophorigenens466,467 has been synthesised via a
convergent strategy.468 Trioxacarcin A, a structurally complex
glycosidic metabolite of terrestrial469 and marine470 Streptomyces
species, has been synthesised via a method which utilised late-
stage stereoselective glycosylation reactions of aglycon
substrates.471 Indoxamycins A, C, and F, cytotoxic tricyclic pol-
ypropionates originally obtained from a Streptomyces sp.472 and
whose stereochemistry has also been revised as a result of a
synthesis of indoxamycin B,473 have been synthesised via a
divergent approach with an Ireland-Claisen rearrangement, a
stereodivergent reductive 1,6-enyne cyclisation and a tandem
1,2-addition/oxa-Michael/methylenation reaction sequence as
key steps.474 Cytosporin D, an epoxyquinone metabolite of
Eutypella scoparia,475 has been prepared from the Diels–Alder
adduct of cyclopentadiene and 2-prenyl-p-benzoquinone,476
while helicascolide B, a lactone originally obtained from the
fungus Helicascus kanaloanus,477 has been synthesised in seven
steps from commercially available tiglic aldehyde.478 Leptosin
D, originally obtained from a Leptosphaeria sp. associated with a
brown alga479 has been synthesised via a strategy which rst
prepared the known terrestrial480 and marine481 fungal metab-
olite gliocladine C, which was then manipulated to access
various tryptophan-derived epidithiodioxopiperazine NPs.482





















































































View Article Online4-hydroxy-2-pyrone metabolite of a Penicillium species associ-
ated with a Thai sea fan Annella sp.,483 was achieved in twelve
steps by a biomimetic bimolecular cascade cyclisation featuring
an intermolecular Michael addition/cyclo-(spiro-) ketalisation
sequence484 and total syntheses of plectosphaeroic acids A–C
(indoleamine 2,3-dioxygenase inhibitors from the fungus Plec-
tosphaerella cucumerina485) have been accomplished.486,487 The
quinoline alkaloid, 4,8-dimethyl-6-O-(20,40-di-O-methyl-b-D-xylo-
pyranosyl)hydroxyquinoline, originally obtained from a Carib-
bean collection of Lyngbya majuscula,488 has been synthesised by
a method which utilises unusual silyl group migrations489 and
synthesis of nhatrangin A, an aplysiatoxin-related metabolite
isolated from Vietnamese Lyngbya majuscula,490 has been
accomplished and conrmed the absolute conguration origi-
nally proposed.491 (+)-Serinolamide A, a cannabinomimetic lipid
metabolite of Panamanian Lyngbya majuscula492 has been syn-
thesised from L-serine in nine steps with 30% overall yield493
and total synthesis of viequeamide A, a cyclic depsipeptide
metabolite of the Puerto Rican “button” cyanobacterium Rivu-
laria sp.,494 was achieved in ten linear steps based on three
retrosynthetic fragments.495 Amphidinolide C, a macrocyclic
lactone metabolite of the dinoagellate Amphidinium sp.,496 has
been synthesised through the use of a common intermediate to
access both the C-1–C-8 and the C-18–C-25 sections.497
3.9 Assorted bioactivities
The sesterterpenes ophiobolin K,498,499 6-epi-ophiobolin K498,499 and
6-epi-ophiobolin G,499 knownmetabolites of both terrestrial498 and
marine499 fungi were isolated from Emericella variecolor (sediment,
Gokasyo Gulf, Mie Prefecture, Japan) as inhibitors of biolm
formation of Mycobacterium smegmatis and of M. bovis BCG at
concentrations below those required for antimicrobial activity.500
Toluquinol, a methylhydroquinone known as a metabolite of the
soil fungusNectria erubescens501was isolated from a Penicillium sp.
(Instituto Biomar, Leo´n, Spain) as an antiangiogenesis agent,
inhibiting the growth of endothelial and tumour cells via
apoptosis aer a cell cycle block and caspase activation.502 Several
known fungal metabolites were isolated as selective inhibitors of
PTP1B, a potential target for the treatment of type 2 diabetes and
obesity.503 Penicillium sp. (sediment, Wan Is., S. Korea) yielded
fructigenine A504 and cyclopenol,505 Eurotium sp. (sediment, Wan
Is., Korea) yielded echinulin506 and avoglaucin507 and a further
Penicillium sp. (unidentied sponge, Jeju Is., S. Korea) was the
source of viridicatol.505 Bis-N-norgliovictin, a known terrestrial508
and marine509,510 metabolite was isolated from a marine-derived
endophytic fungus (no other details given), as an anti-inamma-
tory agent that inhibited LPS-induced TNF-a production in
RAW264.7 cells.511
3.10 Biosynthesis
The gene cluster responsible for the biosynthesis of the glycosy-
lated diazouorene polyketides lomaiviticins A–E,512,117 originally
isolated from Salinispora pacica (formerly Micromonospora
lomaivitiensis), was identied in wild-type Salinispora tropica and
several mutant strains through bioactivity-guided genome
mining.513 An investigation of 163 strains of actinomycetes isolatedThis journal is © The Royal Society of Chemistry 2015from mangrove sediments via homologous screening of the
biosynthetic genes and bioassay identied 16% of the strains as
possessing the potential to produce halogenated NPs.514 The ste-
phacidin and notoamide families of NPs occur in various Asper-
gillus species, both terrestrial515 and marine.516 In a further
elaboration of the biosynthesis of these metabolites, notoamide T
was identied as the likely precursor to stephacidin A and syn-
thesised along with the C-6-epimer, 6-epi-notoamide T. Stephaci-
din A was chemically converted to notoamide T by reductive ring
opening while notoamide T also underwent oxidative conversion
to stephacidin A. [13C]2-Notoamide T was synthesised and fed to
two Aspergillus strains resulting in signicant incorporation into
the advanced metabolite notoamide B.517 Analysis of tran-
scriptome data of a number of saxitoxin (STX)-producing dino-
agellates, especially Alexandrium tamarense strains, identied 265
putative homologues of 13 cyanobacterial STX synthesis genes,
including all of the genes directly involved in toxin synthesis.
Putative homologues of four proteins group closely in phylogenies
with cyanobacteria but the phylogenies do not support transfer of
these genes directly between toxic cyanobacteria and dinoagel-
lates, suggesting that the STX synthesis pathway was likely to have
been assembled independently in cyanobacteria and dinoagel-
lates, but using some evolutionarily related proteins.5184 Green algae
Interest in green alga chemistry continued at a low ebb in 2013.
Further work on Caulerpa racemosa (Zhanjiang coastline,
China), previously the source of caulerpin and two related
caulerpin derivatives,519 led to the discovery of two prenylated
para-xylenes caulerprenylol A 509 and B 510 that were each
weakly antifungal.520
Interesting results were uncovered from the screening and
careful bioassay-guided analysis of a collection of Floridian
marine eukaryotic algae using an ARE-luciferase reporter gene
assay that led to the detection and isolation of three mono-
unsaturated fatty acids 511–513 from Ulva lactuca as activators
of the ARE response. Each contained the identical D7,9-keto
motif.521
A stereoselective synthesis of the C-80–O–C-600 ether of the
antimitotic agent nigricanoside A522 was successfully applied in





















































































View Article Onlinewere reports on the cytotoxic eﬀects of clerosterol from Codium
fragile524 on HTCLs525 and the spasmolytic eﬀects of cau-
lerpine526 on guinea pig ileum.5275 Brown algae
The number of new compounds characterised in 2013 from the
Ochrophyta was again relatively low and was dominated by
terpenoid chemistry. Based on the in vitro cytotoxicity of a crude
Dictyota dichotoma (Abu-Bakr, Red Sea, Egypt) extract an inves-
tigation was mounted and three new diterpenoids (Z)-pachy-
dictyol B 514, (E)-pachydictyol B 515 and pachydictyol C 516
were characterised along with the known pachydictyol A528 and
several other well-known brown algal metabolites.529
Re-investigation of Dilophus spiralis (Elafonissos Is., Greece)
resulted in the isolation of three new dolastanes 517–519 and
ve previously reported perhydroazulenes. The relative cong-
urations were established for all three dolastanes and the
absolute conguration of 518 established by conversion to a
compound of known absolute conguration. The absolute
congurations of 517 and 519 were assumed on the basis of
biogenetic considerations.530
The cytotoxic meronorsesquiterpenoids cystoazorone A 520
and B 521 and meroditerpenoids cystoazorol A 522 and B 523
were isolated from Cystoseira abies-marina (Mosteiros, Sao
Miguel Is., Azores)531 while a series of meroditerpenoids cys-
todione A–F 524–529, all with strong antioxidant properties in
the ABTS assay, were isolated from Cystoseira usneoides
(Gibraltar Strait).532152 | Nat. Prod. Rep., 2015, 32, 116–211The mildly antiproliferative meroditerpenoid zonaquinone
acetate 530 was obtained from a Jamaican Stypopodium
zonale.533 Other known brown algal metabolites were co-isolated
and these included abellinone,534 not previously identied in
S. zonale, stypoldione,535 and sargaol.536 The absolute congu-
ration of 530 was determined by vibrational circular dichroism
(VCD) calculations at several levels of theory.533
The synthesis of the core framework of the proposed struc-





















































































View Article Onlinespectral data of the synthetic analogue did not match sug-
gesting that the originally proposed structure of sargafuran is
incorrect.538 The data matched better with the known sar-
gachromenol.539 Another total synthesis of ()-ecklonialactone
B,540 as well as the non-natural (+)-9,10-dihydro-ecklonia-
lactone B, was reported.541 In papers covering biological
properties of brown algal metabolites, four papers were pub-
lished on the eckol group of phlorotannins describing anti-
inammatory properties,542,543 induction of apoptosis in
carcinoma cells544 and potential as SARS inhibitors.545 Two
surveys were published on the antioxidant potential of brown
algal extracts which included an excellent summary from
species across the phylum as well as the properties of indi-
vidual brown algal metabolites.546,547 The antiviral properties
of sulfoquinovosyldiacylglycerols from Sargassum vulgare
(Ilha de Itacuruça´, S.E. Brazil) were evaluated548 and the anti-
viral activity of Dictyota diterpenes assessed in docking studies
against HIV-1 reverse transcriptases.549 A putative inhibitory
mechanism for RANK-induced osteoclast formation by sar-
gachromanol G from Sargassum siliquastrum550 has been
proposed551 and the antiplatelet and antithrombotic eﬀects of
sargahydroquinoic and sargaquinoic acids determined.552 In
other reports of biological testing, the strong antimelanogenic
properties of an extract from Dictyota coriacea (Jeju Is.,
S. Korea) were attributed to 1,9-dihydroxycrenulide553 and
epiloliolide,554 known compounds.555 Seven known mer-
oditerpenoids were isolated from Sargassum siliquastrum (Jeju
Is., S. Korea) and evaluated for cytotoxicity against a range of
HTCLs,556 while the cytotoxic sterol (24R)-hydroperoxy-24-
vinylcholesterol557 was reported for the rst time from Niza-
muddinia zanardinii (Oman Sea).558 In a comprehensive study
the anticancer eﬀects of fucoxanthin were examined from a
mechanistic perspective.559 In another wide-ranging study, 20
green and brown algal extracts from the French coast
were evaluated against Trypanosoma brucei rhodesiense
(T. b. rhodesiense).560 The Bifurcaria bifurcata extract showed
the strongest trypanocidal activity which was tracked to ele-
ganolone.561 The potential of the HPLC/NMR technique for
chemical proling and dereplication was illustrated with the
characterisation of nine known compounds from Cystophora
torulosa (Pt. Lonsdale, Victoria, Australia).562
6 Red algae
The nine new compounds reported from red algae in 2013 is a
marked reduction in the number reported from the previousThis journal is © The Royal Society of Chemistry 2015year (47). The relative congurations of the 30 stereogenic
centres in the macrodiolide luminaolide 531 (Hydrolithon rein-
bodii)563 were assigned from NMR data, although the relation-
ships of the two side chains to the macrolide ring are still to be
established.564
The structures of laurefurenynes A 532 and B 533 (Laurencia
sp.)565 were reassigned following syntheses of 532566 and 533,567
respectively, and density functional theory (DFT) calculations of
NMR chemical shi data.567 There is still doubt about the
conguration of the closely related elatenyne (L. elata).568
Computational569 and synthetic570 eﬀorts suggested a revised
structure. However, recent more extensive NMR and chemical
derivatisation studies proposed a further revision 534 but were
unable to establish the absolute conguration.571
Various aspects of the congurations of armatols A–F
(Chondria armata)572 have now been claried through the total
synthesis of armatol A 535 and hence by analogy to the struc-
tures for armatols B–F 536–540.573 This paper also reported the
rst total synthesis of dioxepandehydrothyrsiferol (Laurencia





















































































View Article OnlineThe chamigrane sesquiterpenes yicterpene A 541 and B
542 were isolated from L. composita (Pingtan Is., China).575 Of
the 7 compounds isolated from L. similis (Sepanggar Is., Kota
Kinabalu, Sabah), ent-1(10)-aristolen-9b-ol 543 was claimed
as an enantiomer of a known compound.576,577 Two bromo-
phenols 544 and 545 with radical scavenging activity were
obtained from Symphyocladia latiuscula (Qingdao, Shandong
Province, China).578 This same collection of S. latiuscula also
provided the weakly antifungal bromophenol sulfoxide
546.579
One new (547) and three known bromophenols isolated from
Vertebrata lanosa (Oldervik, Ullsorden, Norway) had cellular
antioxidant activities, the rst time this activity has been
reported for this class of compounds.580 The unprecedented
polybrominated spiro-trisindole similisine A 548 and its enan-
tiomer similisine B were obtained from Laurencia similis (S.
China Sea).581
Synthesis of the two proposed diastereomers of prevezol C
(L. obtusa)582 showed that neither is the structure of the NP.583
Parguerenes (L. liformis)584 were identied as inhibitors of P-
glycoprotein (ABCB1) in multidrug resistant human cancer
cells.585 Five known bromophenols from a variety of red algae
had inhibitory activity against glucose 6-phosphate154 | Nat. Prod. Rep., 2015, 32, 116–211dehydrogenase, this being the rst report of such inhibitors
from red algae.586 Analysis of the metabolite compositions of
seasonal collections of Graciliaria gracilis (Lesina Lagoon,
S. Adriatic Sea, Italy) led to the proposition for using G. gracilis
as a multi products source for biotechnological, nutraceutical
and pharmaceutical applications.587 Bioactive metabolites
isolated from Asparagopsis taxiformis were found to have little
potential for therapy services to sh infected with Strepto-
coccus iniae.5887 Sponges
Even with only 243 new compounds reported in 2013, a signif-
icant decrease in relation to previous years (19% and 33% down
on 2011 and 2012, respectively),589,2 sponges remain the domi-
nant phylum for the discovery of new marine-derived bioactives
(see section 15 Conclusion). The modied sphingoid base hal-
isphingosine B 549 was isolated from Haliclona tubifera (Santa
Catarina, Brazil)590 while taurinated fatty acid 550 was isolated
from Axinella sp. (Hainan Is., S. China Sea).591
The asymmetric total synthesis of the “two-headed” sphin-
goid base rhizochalin C (Rhizochalina incrustata)592 has been
completed.593 An Axinyssa djiferi found attached to mangrove
tree roots (Djifer, Senegal) yielded axidjiferosides A–C 551–553,
a mixture of which inhibited chloroquine-resistant P.
falciparum.594
An acetylated nitrogenous glycolipid 554 was isolated from
Plakinastrella clathrata (Gneerings Reef, Queensland, Australia),
with the absolute conguration conrmed by synthesis of lipid-
chain analogues. The compound was claimed to be a moderate
anti-inammatory by inhibition of PGE2 but no data was





















































































View Article OnlineMycalol 555 is a glycerol ether isolated fromMycale acerata
(Terra Nova Bay, Antarctica). A combination of chiroptical
and Mosher's methods were used to assign the absolute
conguration of this specic inhibitor of human anaplastic
thyroid carcinomas, the most aggressive and currently
untreatable thyroid gland malignancies, but inactive
against other solid tumours.596 The absolute conguration
of topsentolide C2 556 (Topsentia sp.)597 was established
by total synthesis of four possible diastereomers.598
The moderately antimicrobial fatty acid trimer man-
zamenone O 557 was isolated from Plakortis sp. (Manzamo,
Okinawa).599
Sponges from the genus Petrosia continue to be a rich
source of new polyacetylenes. The report of petrosiols A–E
558–562 from Petrosia strongylata (Ishigakijima Is., Okinawa)
as inducers of nerve growth factor-like neuronal diﬀerentia-
tion in PC12 cells was followed rapidly by reports of the total
synthesis and absolute conguration of petrosiol D 560,600,601
and the discovery that 558 inhibits proliferation and migra-
tion of platelet derived growth factor-induced vascular
smooth muscle cells and hence could be used as a lead for
vascular disorders.602
The absolute conguration of the isolated methyl group of
miyakosyne A 563 (Petrosia sp.)603 was established by chem-
ical degradation and subsequent esterication with Ohrui'sThis journal is © The Royal Society of Chemistry 2015acid,604 thus correcting an earlier tentative assignment made
from an analysis by X-ray crystallography of miyakosyne
absorbed in a porous metal complex.71,605 A racemic mixture
of C20 bisacetylenic alcohols 564 and 565 has been isolated
from Callyspongia sp. (Iriomote Is., Okinawa), and separated
by chiral HPLC. Total synthesis of both enantiomers and
detailed biological evaluation showed 564 was more active
than its enantiomer against HeLa and temperature sensitive
rat lymphatic endothelial cells, thus dening the 1-yne-3-ol
moiety as an essential pharmacophore.606 Petrosiacetylene E
566 (Petrosia sp. Dokdo Is., S. Korea) was a low mM inhibitor
of multiple HTCLs.607
Petrosynic acids A–D 567–570 (Petrosia sp., Tutuila, Amer-
ican Samoa) all displayed similar activity versus various HTCLs
and non-proliferative human broblasts and hence no thera-
peutic window is available.608
A New Caledonian Niphates sp. was the source of neph-
eliosyne B 571.609 Examination of Petrosia solida (Amami-Osh-
ima, Japan) yielded petroacetylene 572 that inhibited starsh





















































































View Article OnlineBromoacetylene testafuran A 573 was isolated from Xesto-
spongia testudinaria (Iwo Is., Kagoshima, Japan) along with four
other polyacetylenes 574–577, all ve of which induced apido-
genesis (stimulation of the diﬀerentiation of preadipocytes to
adipocytes), and hence may act as leads for treatment of
cardiovascular disorders.611
An inhibitor of starsh egg maturation, bromotheoynic acid
578, was reported from Theonella swinhoei (Tanegashima,
Kagoshima, Japan),612 while two further bromopolyacetylenes
579 and 580 were obtained from Haliclona sp. (Sharm Obhur,
Jeddah, Saudi Arabia).613156 | Nat. Prod. Rep., 2015, 32, 116–211Phosphoiodyns A 581 and B 582 are iodinated and phos-
phate containing alkynes from Placospongia sp. (Tong-Young
City, S. Korea). Phosphoiodyn B was inactive, but 581 was a
potent inhibitor of human peroxisome proliferator-activated
receptor delta (hPPARd) with 200-fold selectivity over other
PPARs, and therefore a potent regulator of lipid and glucose
metabolism, and potentially a lead for treating type 2 diabetes
or metabolic disorders.614,615
Four mono- or di-iodinated polyacetylene acids were isolated
from Suberites mammilaris (583 and 584) and S. japonicus (585
and 586) (Gageo Is., S. Korea). Anti-inammatory bioactivity
proling of the methyl esters indicated that pre-treatment with
the S. mammilaris metabolites inhibited nitrite production in
LPS-stimulated RAW 267.4 macrophages while the S. japonicus
metabolites inhibited NO production in BV2 microglial cells,
with each pair being inactive in the other assay.616
A mixed extract from Smenospongia aurea, S. cerebriformis
and Verongula rigida (Key Largo, Florida) yielded a linear phenyl
alkene 587 with activity against HL-60 cells. Molecular model-
ling docking studies suggested that 587 had a pharmacophore
similar to that of eribulin and hence potential to interfere with
microtubule dynamics.617 Dysideolides A 588 and B 589 are
methyl-branched lactones from Dysidea cinerea (Lang Co Beach,
Vietnam),618 while 12-manadoperoxide B 590, manadoperoxidic
acid B 591 and monoester 592 were reported from Plakortis lita
(Bunaken Is., Manado, Indonesia). Both 591 and the likely
oxidative breakdown product 592 showed potent anti-





















































































View Article OnlineSix newmethylated peroxidic acids 593–598were isolated from
Plakortis simplex (Keomun Is., West Sea, S. Korea). All showed low
moderate cytotoxic activity against RAW264.7 cells.620
A chemical ecological study of Discodermia dissoluta held in
Santa Marta, Colombia has shown that <40 kg of sponge could
be suﬃcient to sustainably produce 1 g of discodermolide621
over six months for clinical trials.622 A comprehensive study
combining computation, chemical derivatisation and NMR
studies was used to assign both the relative and absolute
congurations of plakilactones G 599 and H 600 from a Fijian
Plakinastrella mamillaris.623
Plakortoxides A 601 and B 602, simplextones C 603 and D 604
and plakorsin D 605 were all isolated from Plakortis simplex
(Yongxing Is., S. China Sea) although only 603 showed activity.624This journal is © The Royal Society of Chemistry 2015A two-sponge association between Plakortis communis and
Agelas mauritiana (Mooloolaba, Queensland, Australia) yielded a
new peroxy acid 606.625 Plakinastrella mamillaris (Fiji Is.)
produced plakortides R–U 607–610. Congener 610 was a potent
antimalarial agent against chloroquine-resistant P. falciparum.
The remaining compounds were less active and none of the
compounds were cytotoxic against Vero cells at much higher
concentrations.626
Gracilioether K 611 is a Pregnane X-Receptor (PXR) agonist
with no activity against the Farnesoid X-Receptor isolated from
Plakinastrella mamillaris (Fiji Is.). In silico docking studies sug-
gested a similar binding motif to other gracilioether conge-
ners.627 The sponge Hippospongia lachne (Xisha Is., S. China Sea)
provided hippolachnin A 612, a compound with an unprece-
dented carbon skeleton, that was potently antifungal, but had
no activity against three cancer cell lines. The absolute cong-
uration of 612 was determined from comparison of calculated
and experimental electronic circular dichroism (ECD)
spectra.628
Manzamenones L–N 613–615 were isolated from Plakortis sp.
(Manzamo, Okinawa). Manzamenones M and N showed some
antimicrobial activity against E. coli, S. aureus and Cryptococcus
neoformans (C. neoformans), while manzamenone L (isolated as
a racemate) was inactive.629
Callylactam A 616was isolated from Callyspongia sp. (Hainan
Is., China),630 while allos-hemicalyculin 617 was reported from
Discodermia calyx (Shikine-Jima Is., Japan). Photo-oxidative
cleavage of the oxazole moiety of calyculin A was suggested as a
route to the formation of 617.631 The lipopeptide ciliatamide D
618 was found from a dredged Stelletta sp. (170 m, Oshima-
shinsone seamount, Japan).632 This study also reaﬃrmed the





















































































View Article Onlineassigned during the original isolation,633 and subsequently
incorrectly reassigned by synthesis.634
The sponge Lithoplocamia lithistoides (Madagascar)
produced PM050489 619 and PM060184 620, polyketide amides
that diﬀer only in the presence of a chlorine atom. Both are
active at sub-nanomolar levels against several cancer cell lines.
The gram-scale total syntheses of each compound were also
reported. PM060184 620 has undergone a remarkably rapid
development from the source sponge collection in 2005 through
isolation, characterisation and synthesis in 2006, to the
commencement of phase I clinical trials in 2011.635
A detailed study of the terrestrial myxobacterial genera Sor-
angium and Jahnella has delineated the biosynthesis of the
microsclerodermins, unusual peptides isolated from Micro-
scleroderma and Theonella sponges,636,637 hence suggesting the
likely microbial origin of these NPs.638 Gombamide A 621, a
disulde linked hexapeptide, was isolated from Clathria gom-
bawuiensis (Gageo-Do, S. Korea).639 Stylissatin A 622, a cyclic
heptapeptide from Stylissa massa (Loloata Is., Papua New
Guinea), inhibited NO production in LPS-stimulated macro-
phages,640 while euryjanicins E–G 623–625 are phenylalanine-
and proline-rich heptapeptides from Prosuberites laughlini
(Puerto Rico).641158 | Nat. Prod. Rep., 2015, 32, 116–211Although the structure of the NP is yet to be reported, the
proline-rich octapeptide phakellistatin-19 626 has been syn-





















































































View Article Online440–515 nM vs. three cell lines) and synthetic (not active)
versions diﬀer signicantly, a puzzling discrepancy that has
been noted previously.642,643
The antifungal activity of the theonellamides (Theonella
sp.)644 has been linked to their ability to bind to the 3b-OH of
sterols in lipid bilayers. This was established using solid state
2H-NMR and surface plasmon resonance spectroscopies.645
Sulnyltheonellapeptolide 627 and theonellapeptolide If 628
were isolated from Theonella swinhoei (N. Sulawesi, Indonesia),
both with similar activities against HepG2 hepatic carcinoma
cells.646The total synthesis of yaku'amide A 629 (Ceratopsion sp.)647
established the conguration of the C-terminal methyl. Altering
the conguration of the methyl had no signicant eﬀect onThis journal is © The Royal Society of Chemistry 2015bioactivity.648 Asteropsin A 630 (Asteropus sp., Geoje Is., S. Korea)
is a cysteine-knot peptide with an unusual N-terminal pyroglu-
tamate residue that enhanced neuronal Ca2+ inux in murine
cerebrocortical neuron cells and therefore may be useful for the
treatment of topical pain or hypertension.649
The total syntheses of 18-epi-latrunculol A (Negombata mag-
nica)650 and haliclamide (Haliclona sp.)651 have been achieved,
with the latter study determining the absolute conguration 631
of the NP.652,653 Two separate collections of Pachastrissa nux (Koh
Tao, Surat Thani Province, and Chumphon Is. National Park,
Thailand) yielded the antimalarial trioxazole macrolide kabir-
amide L 632.654A comprehensive study using J-based conformational anal-
ysis, the universal NMR database and chemical derivatisations,
established the absolute congurations of theonezolide A–C
633–635, originally isolated from a Theonella sponge.655–657
Theonella swinhoei (Bunaken Marine Park, Manado, Indo-





















































































View Article OnlineInterestingly 636 was completely inactive while 637 showed
signicant potency against HepG2 cells consistent with other
swinholide congeners.658
The absolute conguration of ()-dysibetaine CPa 638 (Dys-
idea herbacea)659 was established by total synthesis, although
the current study incorrectly mentions Lendenfeldia chondrodes
as the original source.660
The synthesis of nakinadine C (Amphimedon sp.)661
conrmed the absolute structure.662 Synthesis also conrmed
the structures of batzellasides A and C (Batzella sp.).663,664
Manzamine A (Haliclona sp.)665 inhibited autophagy, and hence
could prevent pancreatic cancer, by uncoupling vacuolar
ATPases,666 as well as suppressing hyperlipidaemia and hence
atherosclerosis in apoE-decient mice.667 Zamamiphidin A 639
is a moderately antibacterial (S. aureus) manzamine-type alka-
loid isolated along with ircinic acid 2 640 from Amphimedon sp.
(Zamami, Okinawa).668160 | Nat. Prod. Rep., 2015, 32, 116–211The synthesis of two unstable stereoisomers of 'upenamide
(Echinochalina sp.)669 has shown that the putative structure was
incorrect, although the constitution of the NP could not be
established and given the paucity of remaining compound,
structural revision will be diﬃcult.670 The sponge Haliclona sp.
(d'Urville Is., New Zealand) yielded dehydrohaliclocyclins C 641
and F 642 but lack of material prevented bioactivity proling.671
Plakortis simplex (Keomun Is., West Sea, S. Korea) provided two
regioisomeric alkylpyridinium carboxylates 643 and 644.620 The
pyridinium diamine callyimine A 645 was obtained from Call-
yspongia sp. (Hainan Is., China).630
Synthesis conrmed the structures of amphimedosides A–C
(Amphimedon sp.).672,673 Pyrinodemins G–I 646–648 are bis-3-
alkylpyridinium alkaloids from Amphimedon sp. (Okinawa),
although the exact positioning of the alkyne functionalities is
uncertain and hence the compounds are likely a mixture of





















































































View Article OnlineHigh-level DFT calculations helped conrm the unusually
deshielded 13C chemical shis found in trikentramides A–D
649–652, isolated using an NMR-guided approach from Tri-
kentrion abelliforme (East Point Bommies, Northern Terri-
tory, Australia).675 The synthesis of igzamide (Plocamissa
igzo)676 was achieved.677 Three 5-hydroxyindole compounds
653–655 were reported from Scalarispongia sp. (Dokdo, S.
Korea).678
Hyrtioreticulin F 656 was obtained from Hyrtios reticulatus
(N. Sulawesi, Indonesia) and is the likely product of a Pictet–
Spengler reaction between tryptophan, alanine and glycine.679
The bis-indole 60'-debromohamacanthin A (Spongosorites sp.)680
inhibited angiogenesis by suppressing vascular endothelial
growth factor VEGFR2-mediated PI3K/ALT/mTOR signalling in
human umbilical vascular endothelial cells and mouse embry-
onic stem cells.681
Hyrtioerectines D–F 657–659 are indolo-b-carboline alka-
loids from a Red Sea Hyrtios species, with all three showing
antimicrobial and radical scavenging activity.682 Two bromi-
nated indolo-carbazoles 660 and 661 were isolated from aThis journal is © The Royal Society of Chemistry 2015deep water Asteropus sp. (oﬀshore from Bimini, Ocean Cay,
Bahamas). While catechol 660 showed antimicrobial activity
(C. albicans and MRSA), sulfonate 661 was completely
inactive.683
Hyrtimomines A–C 662–664 are 5-hydroxyindole alkaloids
from Hyrtios sp. (Kerama Is., Okinawa), although only 662
showed activity against tumour cells.684 Hyrtimomines D 665
and E 666 from the same collection are bisindole dimers with
some activity against C. albicans, C. neoformans, S. aureus and





















































































View Article OnlineThe Australian sponge Plakortis lita (Tydeman Reef,
Queensland) yielded thiaplakortones A–D 667–670 following
HTS of a library of 202 983 fractions from 18 453 extracts. All
were potent inhibitors of P. falciparum with 667 showing greater
than 60-fold selectivity for Plasmodium over human embryonic
kidney cells.686 The total syntheses of zyzzyanones A–D (Zyzzya
fuliginosa)687,688 have been achieved.689 Atkamine A 671 is a new
pyrroloiminoquinone isolated from a deep water Latrunculia sp.
(Aleutian Is., Alaska). Olen metathesis was used to identify the
location of the side-chain alkene of this surprisingly inactive
metabolite.690Of four new aaptamine-derivatives 672–675 (Aaptos sub-
eritoides, Ambon, Indonesia) only 674 showed any activity
against murine lymphoma.691 The total synthesis of 2-deoxy-2-
aminokealiiquinone (Leucetta chagosensis)692 conrmed the
structure of the NP.693
Pulchranins A–C 676–678, isolated from two dredged Mon-
achora pulchra samples (Kuril Is. Chain, Russia), were moder-
ately active inhibitors of the transient receptor potential
cationic channel subfamily V (capsaicin receptor), and hence
are pain and thermal reception modulators.694,695 The same
sponge that yielded pulchranins B and C also yielded162 | Nat. Prod. Rep., 2015, 32, 116–211monanchomycalin C 679, a modest inhibitor of MDA-MB-231
breast cancer cells.696
Spongiacidin C (Stylissa massa, Indonesia)697 is the rst
selective inhibitor of USP-7 over other ubiquitin-specic-pro-
cessing proteases to be isolated from a natural source, and
hence is a new lead as an oncological therapeutic.698 Nagela-
mides U–Z 680–685 are bromopyrrole alkaloids from Agelas sp.
(Kerama Is., Okinawa) with a variety of biological activities,
especially the inhibition of the growth of C. albicans. Congeners





















































































View Article OnlineThree new bromotyrosine compounds 686–688 were isolated
from Aplysina sp. (Ladda Reef, S. China Sea),701 while the
structures of ma'edamines A and B (Suberea sp.)702 have been
conrmed by synthesis.703
Pseudoceratina verrucosa (Hook Reef Lagoon, Queensland,
Australia) yielded pseudoceralidinone A 689 and aplysamine 7
690, with the absolute congurations established by Mosher's
method and by total synthesis, respectively. The latter
compound inhibited the growth of PC3 prostate adenocarci-
noma cells while the former was inactive.704
Eight new bromotyrosine derivatives of the psammaplysin
691–693, ceratinamide 694 and subereamide 695–698 classesThis journal is © The Royal Society of Chemistry 2015were isolated from Suberea sp. (Chuuk, Federated States of
Micronesia). Only psammaplysin X 691 and the 19-hydroxy
derivative 692 showed activity against six HTCLs.705
Sesquibastadin 699 (Ianthella basta, Ambon, Indonesia) is a
trimer of hemibastadin that inhibited a variety of protein
kinases from a panel of 24 enzymes, but had no eﬀect on the
proliferation of murine lymphoma cells (L5178Y).706
The Verongid sponges Ianthella basta and Aplysina cav-
ernicola were examined for the presence of brominated skeletal
components within their organic and siliceous matrices. The
conclusions drawn from this work were that the bastadin and
aerothionin compounds found are likely of microbial origin
and that the known secondary metabolites are not associated
with the sponge skeletons. However, a considerable quantity of
brominated mass was found within the skeleton and it is





















































































View Article Onlinesecondary metabolites with a defensive role.707 Reticulatins A
700 and B 701 are dimethylimidazolium cations isolated from
Hyrtios reticulatus (N. Sulawesi, Indonesia). Surprisingly, they
diﬀer in absolute conguration of the side chain carbinol.679
Bis-uracil 702 was isolated from Agelas clathrodes (Yongxing
Is., S. China Sea).708 A Fasciospongia sp. (Weizhou Is., Guangxi,
China) gave the sesquiterpene alkaloid fasciospyrinadine 703,709
while Dysidea avara (Fethiye, Turkey) yielded the mer-
osesquiterpenoid N-methylmelemeleone-A 704.710
Samples of Dactylospongia elegans collected in both Malaysia
and Palau contained the related 5,8-di-epi-ilimaquinone 705,
4,5-di-epi-dactylospongiaquinone 706, 8-epi-dactyloquinone
707, 10,17-O-cyano,4,5-di-epi-dactylospongiaquinone 708 and
cyclospongiacatechol 709. All ve compounds showed anti-
proliferative eﬀects at high concentrations while 706 and 707
also activated Hypoxia Inducible Factor-1 (HIF-1), with the 1,4-
benzoquinone moiety demonstrated as essential for activity.711164 | Nat. Prod. Rep., 2015, 32, 116–211The asymmetric total synthesis of strongylin A (Strongylophora
hartmani)712 conrmed the absolute conguration,713 while
synthesis of dysideavarone A (Dysidea avara)714 conrmed the
structure and also provided material to demonstrate the com-
pound's potent antimicrobial activity, especially against Gram-
positive bacteria, in particular various Staphylococci spp.715 The
bisabolane sesquiterpenoids 3-oxobolene 710 and 1-oxocurcu-
phenol 711 were isolated from Myrmekioderma sp. (Phi-Phi Is.,
Thailand) and were potent inhibitors of HT-29 cancer cells.716
Ianthellalactams A 712 and B 713 (Ianthella abelliformis, Port
Philip Heads, Victoria, Australia) did not inhibit Glycine-gated
chloride channel receptors (GlyR) like other related glycinal lac-
tams.717 Euryspongins A–C 714–716 (Euryspongia sp., Iriomote Is.,
Okinawa) have rare six- or eight-membered skeletons with either
fused furan or g-lactone rings. The presence of the C-4 hydroxyl
group in all three compounds was thought to totally abrogate





















































































View Article OnlinePhorbasin H, originally isolated from Phorbas gukulensis719
but diﬀering from another structure with the same name from
Phorbas sp.,720 inhibits the hypha-specic HWP1 and ALS3
mRNAs of C. albicans, preventing the yeast-to-hyphae transition
and therefore inhibits virulence of the pathogen.721 Axistatins 1–
3 717–719 are pyrimidine diterpenoids from Agelas axifera
(Koror, Republic of Palau). All three were low mM inhibitors of
various human and murine cancer cell lines, as well as being
potent broad-spectrum antibiotics against several Gram-posi-
tive and negative bacteria.722
Phenotypic screening using zebra sh as a genome-wide
eukaryote assay identied kalihinol F (Acanthella sp.)723 as a
copper chelator, resulting in abnormal development as indi-
cated by an undulating notochord, and both pigmentation and
neural defects. This study exemplies the use of zebra sh as a
viable chemical genetic tool for assessing bioactives in a
complex eukaryotic organism.724 The total syntheses of cyan-
thiwigins A, C (Epipolasis reiswigi)725 and H (Myrmekioderma
styx)726 have been achieved, conrming the absolute struc-
tures.727 Hamigera tarangaensis (Cape Karikari, North Is., New
Zealand) provided hamigerans F–K 720–725, 10-epi-hamigeran
K 726, 4-bromohamigeran K 727, hamigeran L 728 and the
methyl ester 729, hamigeran A ethyl ester 730 and an unrelated
congener of epi-verrucosane 731. All but the latter compound
inhibited the growth of HL-60 cells while chemical genetic
screening using yeast as a model organism showed that theThis journal is © The Royal Society of Chemistry 2015mode of action of the antifungal hamigeran G 721 was via
inuence of Golgi function and Golgi vesicle formation.728
Two new isoneoamphilectane diterpenes 732 and 733 were
isolated from Svenzea ava (previously described as Pseudoax-
inella ava) (Great Inagua Is., Bahamas). The absolute cong-
urations of these compounds were secured by comparison of
experimental and calculated VCD data. Both compounds
inhibited the growth of Mycobacterium, but had no eﬀect on
mammalian cell lines.729 Petronigrione 734 is a cembranoid
dimer from Petrosia nigricans (Haivan, Danang, Vietnam) with
moderate activity against HTCLs,730 while Phorbas gukhulensis
(Gagu-Do Is., S. Korea) yielded the diterpene pseudo-dimers
gukulenin C–F 735–738. All four were cytotoxic against K562
and A549 cancer cell lines but none showed any activity against
various microbes.731
The norsesterterpene cyclic peroxides 13,14-epoxymuqublin
A 739 and the 9,10-epoxy isomer 740 were isolated from Diac-
arnus erythraeanus (Elfanadir, Hurghada coast, Egypt). Both





















































































View Article OnlineCollections of the Homoscleromorpha sponge Oscarella
balibaloi at two sites near Marseilles (Mediterranean Sea) yiel-
ded the glucosidated sesterterpenes balibaloside 741, 60 0-O-
acetylbalibaloside 742, 60 00-O-acetylbalibaloside 743 and 600,60 0 0-
O-diacetylbalibaloside 744. These metabolites are the rst gly-
cosidated sesterterpenes reported and although tested in a wide
variety of assays, proved to be inactive.733
Hyrtios communis (Northern Reef region, Palau) yielded
thorectidaeolide A 745, the 4-acetoxy congener 746, and
thorectidaeolides B–E 747–750. Compounds 745–747 inhibi-
ted HIF-1 yet did not show any antiproliferative eﬀects
against the parent T47D or NDA-MB-231 breast cancer cell
lines.734166 | Nat. Prod. Rep., 2015, 32, 116–211A Canadian Phorbas sp. (Ansell Point, Howe Sound, British
Columbia), provided four distinct sesterterpenes ansellone B
751, phorbadione 752, secoepoxyansellone A 753 and alota-
ketal C 754. The latter compound showed similar levels of
activation of cAMP signalling to the standard probe,
forskolin.735
Five new sesterterpenes were reported from three
diﬀerent Psammocinia sp. (various locations in New South
Wales and Victoria, Australia). Ircinianin lactam A 755, the
sulfate derivative 756, oxoircinianin 757, oxoircinianin
lactam A 758 and ircinianin lactone A 759 were all assessed
for GlyR modulating activity with 755 and 758 being
selective and potent potentiators of a3-GlyR and a1-GlyR,
respectively, having potential as leads for treatment of
inammatory pain, epilepsy and both breathing or move-





















































































View Article OnlinePhorbaketals D–K 760–767 and phorbin A 768 were reported
fromMonachora sp. (Gageo Is., Korea), with 764 and 765 weakly
active against A498 cancer cells. The absolute congurations of
all the new compounds were established by Mosher's method
and comparison of CD-curves with known congeners.737This journal is © The Royal Society of Chemistry 2015The scalarane sesterterpenoid hippospongide C 769
(Hippospongia sp., Tai-Tung, Taiwan) had moderate
activity against four HTCLs,738 while 12-deacetoxy-23-
hydroxyscalardial 770, 12-deacetoxy-23-hydroxyhyrtiolide 771
and 12-O-acetyl-16-deacetoxy-23-acetoxyscalarafuran 772
from Psammocinia sp. (S. Korea) were inactive in all assays
used.739Four new scalaranes 773–776 were reported from
Carteriospongia sp. (Nosy Be, Madagascar) with 773 and
774 being signicantly more active than the other two
congeners, indicating the importance of the aldehyde
pharmacophore.740
Cholic acid-3,7-diacetate 777 was isolated as an MNP for
the rst time from Siphonochalina fortis (Bahia Bustamante,
Chubat, Argentina),741 while the 5a,8a-epidioxy sterol
3-acetylaxinysterol 778 was isolated from Axinyssa sp.
(Pingtung, Taiwan).742 Haliclona crassiloba (Dongshan
Is., Guangdong, China) yielded halicrasterols A–D 779–
782 with moderate activity against various microbial





















































































View Article OnlineCyclopropanated sterols aragusterol I 783, 21-O-octadeca-
noyl-xestokerol A 784 and 7b-hydroxypetrosterol 785 were iso-
lated from Xestospongia testudinaria (Truong Sa Archipelago,
Khanh Hoa, Vietnam). Both 783 and 784 had antifouling
potential (growth inhibition of Pseudoalteromonas and Polar-
ibacter bacterial species) at similar levels of activity to the now-
banned antifoulant marine pollutant tributyltin oxide.744
The structure of the unusual autophagy-modulating amino-
sterol clionamine B (Cliona celata)745 was conrmed by
synthesis, which also conrmed the assumed absolute cong-
uration.746 A Corticium sp. (New Britain, Papua New Guinea)
yielded the steroidal alkaloid plakinamine M 786, which dis-
played antitubercular activity.747 Stellettin N 787 is an iso-
malabaricane triterpene acid from Stelletta sp. (Lingshui Bay,
Hainan, China), which along with the other isolated congeners
presented a chemotaxonomic link between three genera within
the sponge order Astrophorida.748168 | Nat. Prod. Rep., 2015, 32, 116–211A dredged Penares sp. (Vietnam) provided six new lanosterol
congeners 788–793. Only 793 showed any signicant activity
against HL-60 cells. A combination of CD and X-ray data allowed
the assignment of absolute conguration for 789 and also
permitted reassignment of the aglycone of eryloside U 794 from
7a,8a to 7b,8b.749,750
Finally, ulososide F 795, urabosides A 796 and B 797 are
triterpene saponins from Ectyoplasia ferox (Caribbean Sea,
Colombia), with 797 being the rst reported compound with
both C-4 methyls elevated to the carboxylic acid oxidation





















































































View Article Online8 Cnidarians
The number of new compounds reported from cnidarians in
2013 (281) has increased by 38% over the average for each of the
previous 10 years. In addition to an epidioxysterol (see later),
three ceramides 798–800 were isolated from Sinularia candidula
(Safaga, Egyptian Red Sea).752 Of the three ceramides, 798 was
the most potent anti-H5N1 virus agent.
Pyrimidinedione 801 was reported from Verrucella
umbraculum (Hainan Is., S. China Sea),753 while Mediterra-
nean specimens of the scleractinian coral Astroides calycularis
aﬀorded the new aplysinopsin analogue 802.754 The highly
strained cyclo-1,3-carbazole structure originally proposed forThis journal is © The Royal Society of Chemistry 2015antipathine A (Antipathes dichotoma)755,756 has been corrected
to the 2,3-carbazole 803 by total synthesis.757 Polyacetylenic
montiporic acid D 804 (Montipora digitata, Sesoko Is.,
Okinawa, Japan) exhibited only mild antibacterial and anti-
oxidant properties.758
New clovane-type sesquiterpenes rumphellclovane C–E 805–
807 and four unnamed variants 808–811 were reported from the
same collection of Rumphella antipathies (Southern Tai-
wan).759,760 The latter four compounds are reported as NPs for
the rst time. Clovane 808 inhibited superoxide generation and
elastase release by stimulated human neutrophils.
Sesquiterpenes capillosanane A–N 812–825 and seco-variants
capillosanane O–R 826–829 were isolated from Sinularia cap-
illosa (Sanya Bay, Hainan Province, China).761 Absolute cong-
urations were established by combinations of chemical
conversions, Mosher's method, CD analysis and biogenetic
reasoning. Capillosanane A exhibited antifouling activity





















































































View Article OnlineFurther examples of tricyclic sesquiterpenes were reported
from Lemnalia philippinensis (philippinlins A 830 and B 831)
collected at Lanyu, Taiwan762 and Paralemnalia thyrsoides
(parathyrsoidins A–D 832–835) collected at Sansiantai, Taitong
County also in Taiwan.763
Spiro-butenolides sinularianins C 836 and D 837 and
potential biosynthetically-related precursors sinularianins E
838 and F 839 were isolated as mild inhibitors of NF-kB170 | Nat. Prod. Rep., 2015, 32, 116–211activation from Sinularia sp. (Dongluo Is., Hainan Province,
China).764
Perezoperezone 840 and curcuperezone 841 (Pseudopter-
ogorgia rigida, Caribbean Sea) are envisaged to arise, in the case
of 840, from non-symmetrical dimerisation of known co-
metabolite perezone765 and in the case of 841, through coupling
of perezone and a-curcumene.766 Flexibilisquinone 842
(cultured specimen of Sinularia exibilis)767 was claimed to be
the enantiomer of sarcophytonone (Sarcophyton crassocaule)768
based upon optical rotation data (842 [a]D 19.6, sarcoph-
ytonone [a]D +5.8).
Of two new C19-norditerpenes 12-hydroxy-scabrolide A 843
and 13-epi-scabrolide C 844 (Sinularia maxima, Nha Trang Bay,
Vietnam) the latter was identied as an inhibitor of the
production of IL-6 and IL-12 by LPS-stimulated bone marrow-
derived dendritic cells.769 In addition to ve sterols (see later), d-
lactone 845 was isolated from Scleronephthya gracillimum
(Green Is., Taiwan) as a modest inhibitor of expression of iNOS
and COX-2 in stimulated macrophages.770 The weakly cytotoxic
spatane diterpene leptoclalin A 846 was reported from cultured
specimens of Sinularia leptoclados.771
As with most years, a diverse array of cembranoid diterpenes
were reported from so corals in 2013. Arbolides A 847 and B
848, epoxy-alcohols with the former also containing a hydro-
peroxide functional group, were obtained from Sinularia
arborea (southern Taiwan).772 Similarly functionalised cem-





















































































View Article Onlinecontaining exibilin C 851 were reported from S. exibilis also
collected from southern Taiwan.773
The absolute conguration of co-metabolite ()-sandenso-
lide (Dendronephthya sp.)774 was conrmed by X-ray crystal
analysis. Of the d-lactones 11-acetylsinuexolide 852 and dihy-
dro analogue 853 (S. exibilis, Pingtung county, Taiwan), only
the former exhibited cytotoxicity as anticipated for an exo-
methylene-conjugated lactone.775 Sinularia exibilis (southern
Taiwan) was also the source of exibilin D 854 and of knownThis journal is © The Royal Society of Chemistry 2015congener 5-dehydrosinulariolide776 the absolute conguration
of which was determined by X-ray crystal analysis.777 The same
publication and a second one778 also described sinulanorcem-
branolide A 855 and the 1-epi-diastereomer 856 from the same
collection of S. gaweli (Sansiantai, Taitung county, Taiwan).
While cembranoid cugibberosene A 857 (S. gibberosa, Ping-
tung, Taiwan)779 was found to be devoid of cytotoxic or anti-
bacterial properties, one of sinulariols T–Z5 858–869 (S. rigida,
Sanya Bay, Hainan Is., S. China Sea), specically 864, exhibited
eﬀects against the model fouling organisms B. amphitrite and B.
neritina.780
The casbane family of cembranoid diterpenes is charac-





















































































View Article Onlinenew examples sinularcasbanes A–F 870–875 (Sinularia sp.,
Ximao Is., Hainan, S. China Sea), 871 and 874 exhibited modest
ability to inhibit NO production by stimulated macrophages.781
Two separate collections of Lobophytum sp. yielded epox-
ycembranes 876–880 (Ximao Is., Sanya Bay, Hainan, China)782
and a-methylene-g-lactones 881–883 (Sanya Bay, Hainan,
China).783 This is the rst report 880 as an NP. Epoxycembrane
878 was a modest inhibitor of NO production by stimulated
macrophages, while 881–883 were each found to be moderately
cytotoxic towards a range of human and murine tumour cell
lines.
Hydroxycembrane sarcophytol W 884 was isolated from
Sarcophyton sp. (Xuwen coral reef area, Guangdong Province,172 | Nat. Prod. Rep., 2015, 32, 116–211China) – absolute conguration was assigned based upon that
determined for a previously reported (Sinularia ovispiculata)784
co-metabolite.785 Sarcophyton ehrenbergi (San-hsian-tai, Taitong
county, Taiwan) was the source of diterpenes ehrenbergol C 885
and acetylehrenberoxide B 886 which both exhibited mild
cytotoxicity (P388) but 886 was more potent as an anti-human
cytomegalovirus agent.786
Of the sarcophyolides B–E 887–890 isolated from S. elegans
(Xidao Is., Hainan, China), the structures and absolute cong-
urations of 887 and 888 were established by X-ray crystal
studies.787
Sarcophyolide B exhibited modest cytotoxicity. Red Sea
collections of S. glaucum aﬀorded 891–893 with 893 being





















































































View Article Onlineequally cytotoxic towards a melanoma and a mouse kidney cell
line, 892 exhibited selectivity towards the tumour cell line. Due
to the presence of the conjugated triene functionality in sar-
glaucol 894 (S. glaucum, Sanya Bay, Hainan, China), it can be
considered a diene-precursor to biscembranoids typically iso-
lated from so corals of the genus Sarcophyton.789
The same collection of S. elegans that aﬀorded sarcoph-
yolides B–E (see earlier) also yielded new examples of an iso-
biscembranoid and biscembranoids, the sarcophytolides G–L
895–900.790 These structures represent minor modications to
previously reported biscembranoids, being a dihydroxylated
analogue of lobophytone F,791 a positional isomer of lobophy-
tone S,792 a methoxylated analogue of lobophytone H,793 a
dehydrated analogue of methyl tortuoate A,794 an oxidised
analogue of lobophytone U795 and a 31-epimer also of lobo-
phytone U, respectively.This journal is © The Royal Society of Chemistry 2015Further investigation of S. latum (Sanya, Hainan Province),
that had previously aﬀorded, amongst other metabolites, bis-
cembranoids bislatumlides A and B,796 has now yielded four
more congeners bislatumlides C–F 901–904.797 Detailed exami-
nation of the absolute conguration of 901 and 903 by time
dependent DFT (TDDFT) calculations of ECD data necessitated
reassignment of the C-21 conguration of bislatumlides A 905
and B 906.Re-isolation of methyl tortuoate D798 (Sarcophyton tortuosum,
Yalong Bay, Hainan, China) has led to its structural revision to
907, with absolute conguration assigned by comparison of
ECD data with that of co-metabolite ximaolide A.799 The study
also concluded that the structure previously attributed to
lobophytone K (Lobophytum pauciorum)800 should also be cor-
rected to 907.
A Red Sea (Hurghada) collection of S. trocheliophorum
provided trochelioids A 908 and B 909 and 16-oxosarcophytonin





















































































View Article OnlineIn three separate accounts, sixteen new cembranoids were
reported from S. trocheliophorum (Yalong Bay, Hainan, China).
Of methyl sarcotroates A 911 and B 912, and sarcophytonolides
M–R 913–918, only hydroperoxide-containing 912 and sar-
cophytonolide N 914 were found to inhibit human PTP1B.802,803
Also isolated were 3-lactone-containing cembranolides sar-
trolide A–G 919–925 and dimer bissartrolide 926.804 The
unusual (1E,3Z)-diene conguration of 925 was supported by174 | Nat. Prod. Rep., 2015, 32, 116–211X-ray crystal analysis of isomeric co-metabolites sarcrassin D805
and emblide.806 Bissartrolide represents a dimer of sartrolide A
and a free carboxylic acid analogue of sarcophytonolide B.807
A total of 34 new briarane diterpenes were reported from two
collections of Dichotella gemmacea: gemmacolides AA–AR 927–
944 (S. China Sea)808 and dichotellides F–U 945–960 (Meishan
Is., Hainan, China).809 The absolute congurations of 927–944
were assigned by comparison of ECD data with those of
dichotellide T 941, the absolute conguration of which was
established by X-ray crystal analysis. Modest to moderate levels
of cytotoxicity were observed for the gemmacolides while the
dichotellides were all poorly cytotoxic with some examples





















































































View Article OnlineJunceella fragilis (Tai-Tong county, Taiwan) was the source of
four more briaranes, frajunolide P–S 961–964.810 Hirsutalins
I–M 965–969 are eunicellin diterpenes isolated from Cladiella
hirsuta (Sianglu Islet, Penghu Is., Taiwan).811 Moderate inhibi-
tion of NO production by stimulated macrophages for 967 was
shown.
In addition to a number of related metabolites, C. kremp
(Weizhou Is., S. China Sea) yielded oxylitophynol 970, litophy-
nol A acetate 971, litophynol C 972 and krempfenin 973.812This journal is © The Royal Society of Chemistry 2015Reduction of 970 gave a product identical to known co-metab-
olite litophynol A,813 subsequent acetylation of which aﬀorded a
product identical to 971.
Also isolated from C. kremp (Penghu Is., Taiwan) were
krempelins E–M 974–982.814,815 Although 974–977 were inac-
tive in antitumour and anti-inammatory assays, structurally
related co-metabolites did exhibit activity.
Of four new eunicellins reported from Cladiella sp. (Penghu
Is., Taiwan), cladieunicellins I 983, K 984, and L 985 and lito-
phynin I diacetate 986, the latter has been previously reported816
as a semi-synthetic derivative.817,818 Cladieunicellins I and L
exhibited moderate activity towards an HTCL.
An unusual member of the klymollins I–S 987–997 (Klyxum
molle, Penghu Is., Taiwan) is the phenylacetate-bearing kly-
mollin M 991.819 This same metabolite was the most potent of
the set, exhibiting cytotoxicity and the ability to inhibit super-
oxide generation and elastase release from stimulated human





















































































View Article Online176 | Nat. Prod. Rep., 2015, 32, 116–211In addition to two eunicellin diterpenes sibogin A 998 and
B 999, investigation of the NPs from Muricella sibogae (Weiz-
hou Is., China) also aﬀorded three new seco-sterols sibogol
A–C 1000–1002.820 A further two seco-sterols 1003 and 1004
were reported from Sinularia nanolobata (Xiao-Liuqiu Is.,
Pingtung county, Taiwan)821 and eleven, subergorgol A–J
1005–1014 and 1015, from Subergorgia suberosa (Meishan
coast, S. China Sea).822 The latter unnamed seco-sterol is
reported as an NP for the rst time. Subergorgols C 1007 and
D 1008, and F 1010 and G 1011 were isolated as their
respective epimeric pairs but with unassigned conguration.
The latter two were considered artefacts of isolation. While
1013 was found to be the most cytotoxic (moderate), 1015 was
devoid of activity.As well as a modestly bioactive d-lactone noted earlier, an
extract of Scleronephthya gracillimum (Green Is., Taiwan) also
aﬀorded pregnanes sclerosteroid J–N 1016–1020.770 Scleroste-
roids K and M were more active than the other metabolites at
inhibiting expression of iNOS and COX-2 in stimulated
macrophages. Pregnane 1021 (Carijoa sp., Weizou Is., S. China
Sea) exhibited potent antimicrobial properties.823
In addition to a number of known congeners, three new
mildly cytotoxic polyhydroxylated steroids 1022–1024 were
isolated from Sarcophyton sp. (Weizhou Is., S. China Sea).824
The possible artefactual origin of methylether 1022 was
noted.
A collection of Anthogorgia caerulea from the same general
location aﬀorded caerulsteroid A 1025.825 Three studies of Red
Sea (Hurghada) cnidarians aﬀorded steroids – hurgadacin 1026
was isolated from Sinularia polydactyla,826 gorgostane 1027 (¼
11-acetyl-sarcoaldosterol A827) from Heteroxenia ghardaqensis828





















































































View Article Onlinetrocheliophorum.829 Zahramycin B exhibited modest antibacte-
rial activity.
Fourteen new sterols 1030–1043, plus one 1044 reported as
an NP for the rst time, were isolated as mildly cytotoxic
constituents of Menella kanisa (coast of Beihai, Guangxi prov-
ince, China).830This journal is © The Royal Society of Chemistry 2015In addition to a number of co-metabolites, muriasteroids
A–C 1045–1047 were identied as weak to moderate cytotoxins
(Muriceopsis avida, Beihai, Guangxi province, China).831 Sterols
containing 24(28)-unsaturation were reported from Sinularia





















































































View Article Onlineand Nephthea chabrolii (nebrosteroids Q–S, 1050–1052, San-
Hsian-Tai coast, Taitong county, Taiwan).833 The latter three
sterols exhibited mild cytotoxicity.
While sterols 1053–1059 (Sarcophyton sp., Weizhou Is., S.
China Sea)834 exhibited variable levels of antimicrobial activity,
dissesterol 1060 (Sinularia dissecta, Hai Van-Son Cha, Hue,178 | Nat. Prod. Rep., 2015, 32, 116–211Vietnam) was a strong inhibitor of IL-12 p40 cytokine produc-
tion by stimulated bone marrow-derived dendritic cells.835 One
new 18-acetoxy sterol 1061 was isolated from a South China Sea
(Xuwen coral reef area) collection of Sarcophyton sp.836
Two 5a,8a-epidioxysterols were reported: mildly cytotoxic
1062 from Sinularia gaweli (Sansiantai, Taitung county, Tai-
wan)837 and antiviral (H5N1) 1063 from S. candidula (Safaga,
Egyptian Red Sea).752
A range of ring-A cross-conjugated steroids, including
lactone side-chained withanolides, were reported from cnidar-
ians. All ve cholestadienones 1064–1068 (Nepthea sp., Naozhou
Is., S. China Sea)838 exhibited cytotoxicity towards a panel of
HTCLs, while of three carboxylic acid-containing examples,
paraminabic acid A–C 1069–1071 (Paraminabea acronocephala,
Pingtung county, Taiwan), 1071 exhibited the most potent
cytotoxicity.839This journal is © The Royal Society of Chemistry 2015










































































































































































View Article OnlineSinubrasolides A–G 1072–1078 are withanolide-type steroids
isolated from cultured specimens of Sinularia brassica (Taiwan)
– the structure of 1075 is notable for containing an unusual
spiroketal moiety.840 Mild cytotoxicity was observed for 1072,
1073 and 1076.
Acetylation of hemiacetal-containing nephthoacetal 1079
(Nephthea sp., Naozhou Is., S. China Sea) yielded two
acetates.841 The NP inhibited the settlement of B. neritina
larvae, an activity not observed for the acetate derivatives,
while all three compounds were mildly cytotoxic to HeLa
cells.
Finally, new steroidal glycosides junceelloside E–G 1080–
1082 were reported from Dichotella gemmacea (Beihai,
China).842 Detailed analysis of the nature of the arabinopyr-
anose subunits (thiocarbamoyl-thiazolidine derivative) iden-
tied junceelloside E to contain the b-L anomer while
junceellosides F and G contained the more standard b-D
anomer. The arabinopyranose unit present in co-metabolite
junceelloside C (Junceella juncea)843 was corrected from b-D to
b-L (1083).The structure of ()-sinularianin B (Sinularia sp.)844 has
been conrmed and absolute conguration established via
synthesis which made use of sulfone-mediated tandem
intramolecular-intermolecular alkylation.845 Comparison of
NMR and chiroptical data for two diastereomers of (+)-sar-
cophytonolide C (Sarcophyton sp.)807 synthesised via a route
including macrolactonisation and transannular RCM steps
has conrmed the structure and established the absolute
conguration of the NP.846 A general strategy for the synthesis
of cladiellin diterpenoid NPs has been exemplied with the
synthesis of ten examples.847 Eﬀorts to mimic the putative
carbon-centred radical reactions proposed for the biosyn-
thesis of selected norcembranoids in Sinularia sp. were180 | Nat. Prod. Rep., 2015, 32, 116–211unsuccessful – a new model pathway was proposed, acting via
a (3 + 2) transannular cyclisation reaction.848 In a related
study, the 5,5,6- and 5,5,7-tricyclic ring systems found in the
cnidarian metabolites plumarellide and rameswaralide were
constructed from linear furanbutenolide precursors under
acidic conditions, suggesting a potential biosynthetic
mechanism involving two-step carbocation cyclisation
sequences.849 Further investigation of the previously reported
anti-inammatory activity of the sesquiterpene lemnalol
(Lemnalia sp.)850 has revealed that intramuscular injection
leads to attenuation of inammation in a monosodium urate
model of human gouty arthritis, and that the NP also sup-
pressed neutrophil inltration and expression of related pro-
inammatory cytokines.851 While the mechanisms of cyto-
toxicity of the cembranoid 5-episinuleptolide acetate852
appear to include inhibition of levels of Hsp90 and induction
of apoptosis,853 11-episinulariolide acetate854 targets EGF-
mediated cytoplasmic calcium levels and inhibits COX-2
and IL-8 expression.855 Of a range of exo-methylene lactone-
containing cembranoids tested for immunomodulatory
eﬀects, lobocrassin B (Lobophytum crassum)856 was the most
eﬀective at blocking TNF-a production and attenuating LPS-
stimulated dendritic cell maturation and endocytosis.857 A
hydroxypropyl-b-cyclodextrin formulation of pseudopterosin
A (Pseudopterogorgia elisabethae)858 was more eﬀective at
inducing HUVEC cell proliferation than a DMSO solution of
the NP – the change in formulation allowed observation of the
decoupling of proliferative and cytotoxic eﬀects.859 The
previously reported ability of hippuristanol (Isis hippuris)860 to
inhibit RNA helicase and eukaryotic initiation factor 4A, hasprompted further investigation of the biological properties of
the spiroacetal-containing steroid, identifying it as an inhib-
itor of primary eﬀusion lymphoma cells, inducing G1 phase
arrest, caspase activation and apoptosis.861 Activity was also
observed in an in vivo model. Further investigation of anti-
inammatory (15R)-prostaglandins from Plexaura homo-
malla862 has identied the metabolites (15R)-PGE2 and
(15R)-OAc-PGA2 as topically active inhibitors of oedema
formation, leucocyte degranulation and elastase enzyme
activity.863 As noted in the previous review in this series,
simplexin Q (Klyxum simplex)864 is a duplicate of klysimplexin
C865 and simplexin S864 is identical to cladieunicellin G





















































































View Article Online9 Bryozoans
Only one new metabolite was reported from bryozoans in the
last year, continuing the trend of minimal NP research eﬀorts
on this phylum. A new alkaloid, 7-bromo-1-ethyl-b-carboline
1084 was isolated from Pterocella vesiculosa (Aldermen Islands,
New Zealand).868
Wilsoniamines A and B, tribrominated alkaloids originally
obtained from an Australian collection of Amathia wilsoni,869
have been synthesised in two steps featuring a condensation
reaction between (2,4,6-tribromo-3-methoxyphenyl)acetalde-
hyde and (S)-N-methylpyrrolidine-2-carboxamide as a
key step.870 Convolutamydine A, a dibrominated oxindole
originally obtained from Amathia convoluta,871 (along
with two synthetic analogues) has/have been shown to
possess antinociceptive eﬀects comparable to those of
morphine.87210 Molluscs
The number of new metabolites reported from molluscs (15) is
just over half the yearly average number reported over the past
decade. The previously noted ability of molluscs to acylate
dinoagellate-produced toxin okadaic acid has been conrmed
with acylating activity located in the digestive gland of various
molluscs.873 A range of unusual D8 unsaturated 4-methyl and
4,4-dimethyl sterols was identied in extracts of the gonads of
the Japanese limpet Cellana grata and C. toreuma.874 Matrix
solid-phase dispersion combined with GC-MS was demon-
strated as a useful technique to detect the presence of bromi-
nated diphenyl ethers and newer halogenated ame retardants
in mussel, cockle and clam extracts.875 New onchidioneThis journal is © The Royal Society of Chemistry 2015analogues 1085–1088 and ilikonapyrone esters 1089–1094 were
reported from diﬀerent Onchidium sp. molluscs.876 Acylation of
1086 gave 1087 and 1088, while reduction of co-metabolite
onchidione aﬀorded two diastereomers, one of which was
identical to onchidionol 1086. The congurational relation-
ships between 1089–1094 were identied by methanolysis of
each, aﬀording a product identical to co-metabolite ilikona-
pyrone.877 Mild cytotoxicity was observed for some of the
compounds.
Two formamide-containing pupukeanane sesquiterpenoid
congeners 1095 and 1096, the latter previously known as a
synthetic derivative, were reported from the tubercle nudi-
branch Phyllidia coelestis (Koh-Ha Islet, Krabi province, Thai-
land).878 Moderate to strong cytotoxicity towards tumour cell
lines was observed.
The absolute conguration of the mildly cytotoxic cyclic
dodecapeptide cycloforskamide 1097 (Pleurobranchus forskalii,
Ishigaki Is., Okinawa) was established by combinations of
ozonolysis and acid hydrolysis.879 In addition to this peptide,
the ergot alkaloid ergosinine880 was also isolated, an unusual
nding as ergot alkaloids are usually only isolated from
terrestrial higher plants and fungi.881
A potentially artefactual hydroperoxide, photo-
tridachiapyrone J 1098 was isolated from the sacoglossan
mollusc Elysia patagonica (San Jorge Gulf, Patagonia,
Argentina).882 The search for new leads for the treatment of
leishmaniasis has identied the known 5a,8a-epidiox-
ycholest-6-en-3b-ol (Dolabrifera dolabrifera) as mildly
active against the amastigote form with nearly sixty-fold
selectivity versus Vero cells.883 The structure of furan 1099
(Hypselodoris jacksoni, S. E. Queensland) was conrmed and
absolute conguration established by a thorough study
using combinations of synthesis, chiral HPLC and MPA





















































































View Article OnlineA new enantioselective route to oxazinin alkaloids (Mytilus
galloprovincialis)885,886 has helped conrm the absolute
conguration of amongst others, oxazinin-1 and -2.887
Synthesis of a library of analogues of cytotoxic depsipeptide
kulokekahilide-2 (Philinopsis speciosa)888,889 has revealed
requirements of conformation, ring formation and ring size
for biological potency.890 Aplysiatoxin (Stylocheilus long-
icauda)891 is a potent PKC binding tumour promoter –
synthesis and evaluation of simplied debromo analogues
suggest that activation of PKCd might play a role in the
observed antiproliferative activity.892 Following the synthesis
of sanguinamide B (Hexabranchus sanguineus),893 the same
group has reported that the use of biotinylated analogues of
two cytotoxic D-Phe analogues in combination with pull-down
assays have identied cellular targets that include eukaryotic
ribosomal subunits.894 Close investigation of the mechanisms
of cell death induced by the compounds indicates that the
exact mechanism depends on the position of the D-Phe group.
The results of a dose-escalating phase I study of kahalalide F
(originally mollusc Elysia rufescens and green alga Bryopsis
pennata)895 have been reported,896 while evaluation of a
kahalalide F analogue, elisidepsin, against a panel of tumour
cell lines suggests that cell lines that exhibit high E-cadherin,
ErbB3 and Muc1 gene expression can be regarded as being
sensitive to the clinical candidate.897 Drug resistance was
associated with the presence of KRAS activating mutations.
Using constrained NOESY NMR data, a conformational search
has helped assign the conguration (3S) in the 9-methyl-3-
decanol subunit of kahalalide Y (Elysia rufescens):898 unfortu-
nately the study made use of the enantiomer of the NP and so
the conguration should in fact be (3R).899,900 Investigation of
the mechanism of cytotoxic action of aplyronine A (Aplysia
kurodai)901 using photoaﬃnity biotinylated derivatives has
identied aplyronine A to synergistically bind to tubulin in
association with actin in a 1 : 1 : 1 ratio, leading to inhibition
of tubulin polymerisation, and ultimately prevention of
spindle formation and mitosis.902 Similar experiments using
aplyronine C902 (lacks the trimethylserine sidechain of aplyr-
onine A;903 three orders of magnitude less cytotoxic) showed it
to bind to actin, as previously reported, but it did not bind to
tubulin in this present study. Model compounds of the
N-methylformamide sidechain of aplyronine A exhibit cyto-
toxicity towards tumour cell lines which is strongly correlated
with their ability to induce the disruption of actin
laments.90411 Tunicates (ascidians)
The 35 new tunicate-derived NPs presented in this review is
average for the number reported per annum over the last182 | Nat. Prod. Rep., 2015, 32, 116–211decade. The sulfonated serinol lipids siladenoserinol A–L 1100–
1111 (Didemnidae, North Sulawesi, Indonesia) inhibited the
interaction of tumour suppressor p53 with Hdm2, potentially
leading to reactivation of p53 and induction of apoptosis in
cancer cells.905 The absolute conguration of 1100 was estab-
lished by a combination of degradation, modied Mosher's
analysis and comparison with similar fragments of dened
conguration.
Two new examples of the rare 1,2,4-thiadiazole ring system,
polycarpathiamine A 1112 and B 1113, were isolated from Pol-
ycarpa aurata (Ambon, Indonesia). While 1112 exhibited sub-
micromolar cytotoxicity (L5178Y), 1113 was inactive.906 The
regiochemistry of the 1,2,4-thiadiazole ring was established by
analysis of 1H–15N HMBC data and by synthesis of a model
compound.
A diverse range of pteridine (duramidines A–D 1114–1117),
thymidine (leptoclinidines A 1118 and B 1119), choline (dura-
betaines A 1120 and B 1121) and imidazole (leptoclinidamines
D–F 1122–1124) analogues was isolated from Leptoclinides durus





















































































View Article OnlineFour methylsulnyladenosine derivatives, momusine A–D
1125–1128, isolated as pairs of interconverting isomers, were
reported from extracts of Herdmania momus (Jeju Is., S.
Korea).908This journal is © The Royal Society of Chemistry 2015The structures of the modestly cytotoxic dioxothiazinomer-
oterpenes conthiaquinone A 1129 and B 1130 (Aplidium con-
icum, Porto Cesareo, Lecce, Italy) were established by
interpretation of NMR data in combination with DP4 calculated
chemical shis.909 The absolute conguration of 1129 was
proposed from TDDFT calculated ECD data.
Four new examples of pyridoacridine alkaloids, shermil-
amine F 1131, dehydrokuanoniamine F 1132 arnoamine C 1133
and D 1134 (Cystodytes violatinctus, Solomon Is.) exhibited
modest cytotoxicity towards a panel of HTCLs.910 A variant
biosynthetic pathway to address the formation of arnoamines C





















































































View Article Onlinestyelsamines911 were prepared and assessed for DNA binding
ability and cytotoxicity.912
A sperm activation and attractant 1135 was isolated from egg
seawater of Ascidia sydneiensis; structure elucidation by NMR
and MS was performed on 2.6 mg (4 nmol) of material.913 The
proposed planar and stereo structure of 1135 was supported by
the synthesis of model compounds. The structure of this sperm
attractant is very similar to that previously reported from Ciona
intestinalis and C. savignyi.914
Synthesis and cytotoxic evaluation of aminol lipids clav-
aminol G915 (Clavelina phlegrea)916 and crucigasterins A, B and
D917,918 (Pseudodistoma crucigaster)919 have been reported; mild
activity was observed. First syntheses of kottamide E920
(Pycnoclavella kottae),921 lukianol B922 (unidentied tunicate)923
and eudistomin Y7924–926 (Eudistoma sp.)927 have been pub-
lished. Syntheses of an isomer of didemnaketal A928 and the
proposed structure of didemnaketal B929 (Didemnum sp.)930
provide further evidence that the NPs require revision of
congurational assignments. Synthesis and structure–activity
relationship studies on orthidine F931 (antimalarial),932 asci-
diathiazone933 (antimalarial),934 meridianin G935 (antima-
larial),936 perspicamide A937 (antileishmanial),938 rigidin939
(antitumour),940 and ningalin B941 (P-glycoprotein modu-
lator)942 have been reported. Further investigation of recently
reported ascidian metabolites of the cadiolide and synoilide
families of furanones (Synoicum sp.)943 has identied cadio-
lides E, H and I as being potent inhibitors of C. albicans iso-
citrate lyase, an enzyme associated with microorganism
virulence.944 Semi-synthetic N-acyl derivatives of ecteinascidin
770 (Ecteinascidia thurstoni)945 has identied quinoline- and
uorocinnamoyl-containing examples that exhibit 50–70 fold
increased cytotoxicity towards the HCT-116 cell line versus the
parent NP.946 Minor corrections to manuscripts describing
the mandelalides (Lissoclinum sp.)947 and herdmanine K
(Herdmania momus)948 have been noted.12 Echinoderms
The 33 new metabolites reported from echinoderms in this
review is lower than the average number reported per annum
over the last decade. A commercially available specimen of the
starsh Asterias rollestoni (Xiamen foodmarket, China) aﬀorded
the tetraosides 1136 and 1137 (ref. 949) while Astropecten poly-
acanthus (Cat Ba, Haiphong, Vietnam) contained the inactive or
mildly cytotoxic sterols astropectenol A–D 1138–1141.950 The
latter set of compounds was also reported to inhibit the
expression of pro-inammatory cytokines in bone marrow-





















































































View Article OnlineAphelasteroside E 1142, which contains the rare sulfation at
C-26, was isolated from Aphelasterias japonica (Poset Bay, Sea of
Japan)952 and the C-24-arabinosides pectinioside H–J 1143–1145
were identied in extracts of Asterina pectinifera (Dalian coast,
Yellow Sea, China).953
Tetraosides typicoside A1 1146 (the 24E isomer of previously
reported intercedenside A (Mensamaria intercedens)954), A2, B1,
C1 and C2 1147–1150 are minor metabolites isolated from the
sea cucumber Actinocucumis typica (Vizhinjam coast, Arabian
Sea, India).955 Antifungal, haemolytic and cytotoxic evaluations
of the ve NPs identied widespread activity, with typicoside C1
being markedly less active in all assays. The presence of dis-
ulfated tetraoside turquetoside A 1151, which contains the rare
3-O-methyl-D-quinovose sugar unit, in both Staurocucumis tur-
queti and S. liouvillei suggests the sugar is a taxonomic character
of this particular genus of Antarctic sea cucumber.956This journal is © The Royal Society of Chemistry 2015Of the disulfated pentaosides cucumarioside I1, I3 and I4
1152–1154 (Eupentacta fraudatrix, Peter the Great Gulf, Sea of
Japan), only 1152 exhibited biological activity including cyto-
toxicity (weak) and haemolytic activity (strong).957 Pentaosides
cladoloside B1 1155 and B2 1156 and hexaosides cladoloside C,
C1, C2 and D 1157–1160 (Cladolabes schmeltzii, Nha Trang Gulf,
S. China Sea) all exhibited similar levels of strong cytotoxicity
and haemolytic activity.958
Extracts of the starsh Astropecten monacanthus (Cat Ba,
Haiphong, Vietnam) aﬀorded the hexaosides astrosterioside
A–C 1161–1163 and pentaoside astrosterioside D 1164.959 While
1161 and 1163 exhibited mild inhibition of IL-6 production by
stimulated bone marrow-derived dendritic cells, diketo-con-
taining 1164 exhibited potent inhibition of production of IL-6,
IL-12 p40 and TNF-a.Nat. Prod. Rep., 2015, 32, 116–211 | 185










































































































































































View Article OnlineThe pyrrole and furan oligoglycosides astebatherioside A–D
1165–1168 were reported from the starsh Asterina batheri
(Catba, Haiphong, Vietnam).960 While 1165 was either inactive
or weakly active, 1166–1168 demonstrated inhibition of IL-12
p40 production, and to a lesser extent of IL-6 production, in
LPS-stimulated bone marrow-derived dendritic cells.
The synthesis of goniopectenoside B (starsh Goniopecten
demonstrans)961 has been reported.962 Puried polar steroids
previously reported from the starsh Patiria pectinifera and
Distolasterias nipon are potent enhancers of neurite outgrowth
and acted as neuroprotectors against damage caused by
oxygen-glucose deprivation.963 Crude preparations of cerebro-
sides from the sea cucumber Acaudina molpadioides and the
starsh Asterias amurensis were found to protect PC12 cells
from oxidative damage due to exposure to H2O2 or tert-butyl
hydroperoxide.964 In both cases the neuroprotection appeared
to be conferred by upregulation of superoxide dismutase
activity and modulation of components of the mitochondrial
apoptotic pathway. High-energy CID tandem mass analysis
has been used to determine the structures of ceramides and
cerebrosides isolated from Distolasterias nipon.965 Stable
isotope biosynthesis feeding experiments have determined
that dietary cholesterol and cholesterol 3-sulfate are elabo-
rated into polyhydroxylated sterols in the starsh Patiria
(¼ Asterina) pectinifera.96613 Mangroves
Aerial parts of the mangrove plant Kandelia obovata (Ximen Is.,
Zhejiang Province, China) aﬀorded two new furofuran lignans
kandelisesquilignan A 1169 and B 1170.967 Similar levels of
antioxidant activity (DPPH assay) were observed for 1169 and
1170 versus ascorbic acid.
Ethanolic extracts of the bark of Ceriops decandra (Godavari
estuary, Andhra Pradesh, India) aﬀorded diterpenes decandrin
A–K 1171–1181, the structures of which encompass abietane
and podocarpane skeletons,968 while the wood of Excoecaria
agallocha (Corangi forest, Godavari estuary) aﬀorded ent-iso-
pimarane diterpenoids agallochaexcoerin D–F 1182–1184.969
Two triterpenes tiliacol A 1185 and B 1186 were isolated
from the semi-mangrove plant Hibiscus tiliaceus (Hainan Is.,
China).970This journal is © The Royal Society of Chemistry 2015A diverse range of liminoids were reported from extracts of
Xylocarpus granatum: granatumins H–K 1187–1190 (seeds,





















































































View Article Onlineand D 1192 (seeds, Hainan Province, China),972 and xylogranins
A 1193 and B 1194 (leaves, Sundarbans Mangrove Forest, Ban-
gladesh).973 Xylomexicanin C 1191 exhibited modest cytotoxicity
towards a breast tumour cell line, while xylogranin B 1194 and
co-metabolite swietephragmin were potent inhibitors of the
Wnt signalling pathway and exhibited sub-micromolar cyto-
toxicity towards two human colorectal tumour cell lines.188 | Nat. Prod. Rep., 2015, 32, 116–211Extracts of the seeds of X. moluccensis (Trang province,
Thailand) aﬀorded thaixylomolins A–F 1195–1200.974,975 The
structure of 1195 was secured by X-ray diﬀraction analysis and
TDDFT calculations were used to establish the absolute
congurations of 1196 and 1197, while 1198 was assigned by
comparison of ECD data. The 4-hydro-dithiosulfonate, bru-
guiesulfurol (Bruguiera gymnorhiza)976 was detected as a modest
inhibitor of PTP1B, prompting its synthesis and preparation of
a library of analogues, some of which exhibited more potent
activity.977
14 Miscellaneous
Investigation of water conditioned with sea lamprey (Petromy-
zon marinus) larvae aﬀorded the hexahydrophenanthrene
sulfate petromyzonin 1201.978 Absolute conguration was
assigned by ECD analysis. Petromyzonin elicited potent
(1011 M) response in electro-olfactogram recordings using
olfactory epithelia of adult male sea lamprey, indicating a likely





















































































View Article OnlineThe detection of 5,11-dideoxytetrodotoxin,979 isolated as an
NP for the rst time, in the puﬀersh Takifugu poecilonotus and
the atworm Planocerid sp. 1 (Guam) prompted speculation on
the putative biosynthetic pathways for the biosynthesis and
metabolism of tetrodotoxins.980 A new method involving soni-
cation, SPE and LC-MS/MS has been reported to allow simul-
taneous quantication of Pacic ciguatoxins-1, -2 and -3 in the
whole blood of sh.98115 Conclusion
Fiy years ago in 1963 just four papers were published on MNPs
with only one paper containing new compounds. At that time
MNPs was becoming established as a eld of interest. In this
Conclusion the phylum-preferences of the MNP community
across the subsequent 50 years period are examined. These
preferences are presented (Fig. 1) as the annual number of
publications reporting the isolation of new compounds for each
phylum that has been sampled over this period. The most
aggressively selected phylum has been the Porifera, but the
popularity of this target has diminished somewhat since the
mid 1990s coinciding with the very rapid rise in popularity of
the Ascomycota, Actinobacteria and the Cyanobacteria. The
Cnidaria have steadily increased in popularity across the years
and while the phyla Rhodophyta, Ochrophyta, Echinodermata
and Mollusca were as popular as the Porifera in the early years,
interest waned in later years. The popularity of these phyla inFig. 1 The phylum-preferences of the marine natural product research
This journal is © The Royal Society of Chemistry 2015earlier years may have been a reection of the relative ease of
collection by snorkeling and shore-wading as in the 1960s and
1970s SCUBA diving was more of a specialist technique. The
numeric totals for the 50 years of collection are given in Table 1
along with the percentage contribution of each phylum to the
marine literature. For the 50 years period from 1963 9220 papers
have reported the isolation of 24 662 new compounds. These
9220 papers constitute 37% of the total papers in MarinLit.77
The other 17 284 papers are associated with topics such as
reviews, syntheses, stereochemistry, corrections of structure or
stereochemistry, bioactivities, and ecological surveys. Other
data shown in Table 1 include the numbers of compounds
reported/phylum over the 50 years period as well as the %
contributions each phylum has made to the number of papers
reporting new compounds or the number of compounds. These
relative proportions are comparable as the number of isolated
compounds reported/paper is 2–3 across most of the phyla. Also
included are the recognised totals of species/phylum from the
World Register of Marine Species (WORMS),982 allowing
comparison of the numbers of samples of each phylum
collected with the actual number of recognised species. This
comparison should be used carefully as multiple collections of
the same species have been made, or the sample may have only
been identied to the genus level. However the comparison
does oﬀer insights into the coverage of each phylum. This point
is emphasised by considering the various contributions the
most studied genus for each phylum has made. For example, forcommunity across a 50-year period from 1963.













































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































View Article Onlinethe Rhodophyta the most studied genus has been Laurencia.
Even though Laurencia is only one of 84 genera studied, this one
genus contributed 369 out of the total 672 papers from the
Rhodophyta describing new MNPs and was the source of 824 of
the 1668 new compounds from this phylum. The important
consideration is that even though multiple collections of the
same genus/species may have been made, the same genus or
species at diﬀerent locations is giving rise to a diﬀerent suite of
metabolites. Apart from Porifera and Cyanobacteria, the
coverage of most phyla is very limited, although the credibility
of the numbers of species recognised by WORMS982 for the
Ascomycota and Actinobacteria is probably suspect as much of
the micro-world has yet to be fully recognised. Over the past 50
years MNP chemists have studied samples collected from 1300
genera across 28 phyla. These 28 phyla represent an estimated
(WORMS) 210 892 marine species out of an estimated total of
224 070 for all marine phyla.982 In other words MNP chemists
have collected widely, but perhaps thinly across the Kingdoms.
The Kingdom Virus (119 representatives) has not been sampled
at all by MNP chemists and so has been excluded from
consideration. As chemists we have published 9220 papers over
the past 50 years describing new compounds from these 28
phyla. But, in fact, the 9220 papers describe compounds elicited
from just 2657 named species with another 2485 occurrences
across 484 genera that are only described as sp. So, the number
of distinct species studied is a long way short of 9220. This
nicely emphasises the point that there is still an enormous MNP
resource waiting to be explored; probably in excess of 200 000
species still to be evaluated.
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